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ABSTRACT
ATP is a multifunctional nucleotide considered to be the “molecular unit of
currency” of intracellular energy transfer. ATP is utilized ubiquitously for the transport of
chemical energy within the cell in addition to acting as a substrate in the regulation of
many metabolic and signaling transduction pathways such as kinase-mediated signaling
cascades. Interestingly, the functional mechanisms of many enzymes require the
binding of ATP to trigger key structural and conformational changes that ultimately
result in enzyme-directed catalysis. Two of the most omnipresent ATPases within the
cell include the V-ATPase rotary proton pump and the Hsp90 protein-folding chaperone.
Structural and biochemical investigations of these enzymes reveal interesting details
and novel binding interactions that further illustrate the role ATP hydrolysis plays in both
the translocation of protons across membranes and hormone receptor activation,
respectively. The 14Å cryo-EM reconstruction of the hydrophilic V1-ATPase provides
insight into the architecture of the peripheral stator stalks as well as revealing a unique
inhibitory interaction between the DF central rotor and the A3B3 catalytic complex.
Additionally, the formation of the Hsp90-FKBP52-p23-HOP complex highlights the
simultaneous binding of two TPR domain-containing proteins to the Hsp90 chaperone.
These particular interactions support the existence of a novel sub-assembly potentially
involved in the regulation of steroid hormone receptor-mediated transcriptional activity.
Collectively the two investigations described below illustrate the omnipotent role ATP
plays in the context of cellular physiology.
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CHAPTER 1
ATP: PHYSIOLOGICAL ROLES AND UTILITIES
1.1

INTRODUCTION
Adenosine 5’-triphosphate (ATP) is a multifunctional nucleotide considered to be

the “molecular unit of currency” for intracellular energy transfer [1]. ATP is utilized
ubiquitously for the transport of chemical energy within the cell in addition to acting as a
substrate in the regulation of many metabolic and signal transduction pathways such as
kinase-mediated signaling cascades [2]. ATP also plays a central role in the synthesis
and repair of DNA and RNA as well as in the translation of RNA into protein [3].
Interestingly, the functional mechanisms of many enzymes require the binding of ATP to
trigger key structural and conformational changes that ultimately result in catalysis. The
omniscient role played by ATP in the physiology of living organisms is further illustrated
from research showing that the intracellular ATP concentration can reach up to 10mM in
some species. Interestingly, the human body contains roughly 250g of ATP at any one
time which can be hydrolyzed at rates between 100-150 moles or 50-75 kg daily [4].
The structure of ATP consists of an adenine base attached to the 1’ carbon atom
of a ribose sugar (Figure 1.1). Three phosphate groups are attached to the 5’ carbon
atom of the sugar and hold the molecular basis of the energy that can be derived from
ATP [5]. Hydrolytic cleavage of the terminal phosphoanhydride bond yielding adenosine
5’-diphosphate (ADP) and free γ phosphate is highly exergonic (∆G’°=-30.5kJ/mol) [6].
Furthermore the α-β phosphoanhydride bond of ATP can also be cleaved to yield
roughly 15kJ/mol more energy than the β-γ bond [1]. ATP is most kinetically stable
under physiological conditions (pH ~7.0) due a high activation energy [6]. Rapid
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cleavage of the phosphoanhydride bonds occurs only in the presence of catalyzing
enzymes.

Figure 1.1 The chemical structure of ATP illustrating the arrangement of the three
phosphoryl groups. Adapted from Fisher and Rice, Biology, 3rd Edition [7].
Our current understanding of ATP synthesis, also referred to as oxidative
phosphorylation, is primarily based on the chemiosmotic theory which stipulates that the
electrochemical energy inherent in the difference in proton concentration and separation
of charge across the inner mitochondrial membrane (the proton motive force) drives the
synthesis of ATP as protons flow passively back into the matrix through the ATP
synthase [8]. Evidence of this came from experiments with an artificially imposed
electrochemical gradient created in isolated mitochondria in the absence of oxidizable
substrate. These results indicated that at lower experimental pHs, the ATP synthase
functioned more efficiently as a result of the larger differential in the proton
concentration in the intermembrane space compared to that in the matrix [9]. In vivo the
mitochondrial electrochemical gradient is indirectly generated through the pathways
associated with aerobic and anaerobic metabolism. Through the processes of βoxidation, glycolysis and the citric acid cycle, food energy can be broken down into the
key reducing intermediates NADH and FADH2, which are oxidized by the enzymatic

2

complexes of the electron transport chain that pump protons to the intermembrane
space. As a final result of NADH oxidation, 10 protons are translocated from the
mitochondrial matrix to the intermembrane space, ultimately resulting in the synthesis of
approximately 2.5 ATP molecules [1,10] (Figure 1.2).

Figure 1.2 A cartoon diagram of the electron transport chain coupled to oxidative
phosphorylation. Adapted from Fisher and Rice, Biology, 3rd Edition [7].
As previously mentioned, the final step in the synthesis of ATP from ADP and
inorganic phosphate requires the rotary mechanism of the ATP synthase enzyme
[11,12,13,14]. This complex holoenzyme consists of a cytosolic F1 catalytic domain
linked to a membranous Fo domain by way of a central rotor stalk [15]. Proton passage
through the Fo pore (oligomycin-sensitive domain) triggers the rotation of the central
stalk γ subunit which interacts with each of the three catalytic β subunits of which
employ three different nucleotide-binding affinities [15,16] (Figure 1.3A). As a result of
conformational changes, the three β subunits are primed for the release of product
(ATP), binding of substrates (ADP and inorganic phosphate) and ATP formation,
respectively [17]. One complete rotation of the γ subunit causes each β subunit to cycle

3

through its three possible conformations, resulting in the synthesis of three ATP
molecules [18,19]. Interestingly, the generation of one ATP requiring the rotation of the
central stalk through 120°, is driven by the translocation of three to four protons across
the inner mitochondrial membrane [16,20]. Direct evidence of this rotary mechanism
was visualized in microscopy experiments in which the rotation of a single γ subunit was
observed in relation to its immobilized α3β3 catalytic domain during ATP synthesis and
hydrolysis [21,22,23] (Figure 1.3B and C). The ATP synthase in eubacteria embraces
this multi-functional mechanism by exhibiting the ability to rotate in both directions
based on the availability of ATP and protons in the cell [12,24].

Figure 1.3 The three dimensional structure of the ATP synthase highlighting its
rotational catalysis. (A) A high-resolution structure of the ATP illustrating the rotation of
the central rotor stalk (γ-blue, ε-green) in relation to the α3β3 catalytic complex (α-red, βyellow). Rotation of the central stalk triggers conformation changes in each of the three
β subunits by which three molecules of ATP are synthesized per 360° revolution [22].
Image adapted from Weber, 2007 [25]. (B) Cartoon schematic of the experimental
design which initially confirmed the rotary mechanism of the ATP synthase [21]. (C)
Observations of F1 Rotation. Video images of a rotating actin filament at intervals of 133
ms [22]. Sub-panels B and C were adapted from Kinosita et al, 1998 [22].
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The primary structural feature through which proteins and enzymes utilize the
energy derived from ATP hydrolysis is a nucleotide-binding motif referred to as a
Rossmann fold [26,27]. This tertiary structure motif is characterized by three of more
parallel β-strands linked together by α-helices (β-α-β-α-β) [26,27]. In the case of
aminoacyl-tRNA synthetases, the Rossmann fold comprises a majority of the
nucleotide-binding pockets, however in some cases such as in the SerRNA synthetase,
ATP is cradled by an anti-parallel β-sheet-based motif [28,29]. Additionally there exists
the GXXXXGK(T/S) Walker motif that is also found in nucleotide-binding proteins that is
derived from the work done by Sir John E. Walker with the ATP synthase [16,30].
Proteins that utilize ATP as part of their functional mechanism do so in the
presence of divalent cations such as magnesium or calcium which stabilize the
negatively charged phosphoryl groups of ATP [31]. In the case of protein kinases, the
activity of these enzymes is greatly affected by the nature and concentration of the
available divalent metal ion [32,33,34,35,36,37]. Interestingly, the presence of
magnesium greatly decreases the dissociation constant of ATP from its respective
protein binding partner without affecting the functional catalysis once ATP is bound [38].
In the proceeding section, the methods by which proteins use ATP for their
molecular function will be discussed. In particular, the ATPase activities of the Hsp90
chaperone and the V-ATPase proton pump will be briefly addressed to illustrate the
importance of ATP in the investigations described in subsequent sections. Additionally
the roles of ATP in chaperonin-mediated protein folding and viable tRNA aminoacylation
will also be discussed to further highlight the central importance of ATP in the vast
context of cellular physiology.
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1.2

ATPase ACTIVITY IN PROTEINS

1.2.1 Hsp90: NUCLEOTIDE-DRIVEN PROTEIN FOLDING
The 90kDa Heat shock protein (Hsp90) is an ATP-dependent molecular
chaperone involved in the folding and activation of a plethora of substrate proteins.
These include various protein kinases and transcription factors [39]. Structurally, Hsp90
consists of highly conserved amino- and carboxy-terminal domains connected by a
highly charged linker [40]. The weak binding of ATP to the amino-termini of the Hsp90
dimer occurs with an association constant of approximately 250µM upon which
approximately one ATP molecule is hydrolyzed every two minutes [41,42,43,44]. Kinetic
analysis of the ATPase activity of Hsp90 revealed that the rate of hydrolysis is
determined by slow conformational changes prior to hydrolysis followed by a slow
hydrolytic turnover [44]. During the ATPase cycle, Hsp90 exhibits amino-terminal
dimerization that is believed to be crucial for maximum ATPase activity and mechanistic
synchronization [45]. As a result, two molecules of ATP are hydrolyzed per round of
amino-terminal dimerization [46]. It is also worth noting that the ATPase activity of
Hsp90 can be influenced by a number of co-chaperone proteins (Figure 1.4A). In
particular, the p23 co-chaperone binds to the amino-termini of the Hsp90 dimer to
protect and essentially control the rate of ATP hydrolysis [47,48]. Additionally the Heat
shock Organizing Protein (HOP) has been found to be a potent inhibitor of Hsp90
ATPase activity, the mechanism of which remains unclear [49].
When bound to Hsp90, ATP adopts a kinked conformation [50]. In this
arrangement the α- and β-phosphates are shielded by the binding pocket while the γphosphate is completely exposed to solution (Figure 1.4B). At the nucleotide interface, a

6

magnesium ion is found in contact with an acidic glutamate residue and is responsible
for stabilizing the exposed γ-phosphate of ATP [50].

Figure 1.4 Structural details of Hsp90 (A) The ATPase cycle of Hsp90 based on recent
crystallographic structures. The slow steps during the ATPase cycle are the
conformational changes preceding ATP hydrolysis. These steps are regulated by Sti1
(HOP), Cdc37 (inhibition), and Aha1 (stimulation). In contrast, the co-chaperone p23
binds to ATP-bound, catalytically active conformation of Hsp90 and slows down ATP
turnover. Figure adapted from Richter and Buchner, 2006 [51]. (B) Key residues in the
binding and hydrolysis of ATP revealed by a close-up view of the amino-terminal
nucleotide-binding site of Hsp90. The water involved in the Asp79-adenine interaction
(ATP in green) is shown as a blue sphere and the essential Mg2+ is shown as a grey
sphere. Figure adapted from Panaretou et al, 1998 [50].
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1.2.2 V-ATPase ROTATIONAL CATALYSIS
Vacuolar ATPases (V-ATPases) couple the transfer of protons across the
membrane with ATP hydrolysis through a catalytic mechanism [52]. V-ATPases are
thought to originate from an ancestral homolog of the F-ATP synthase which also
employs a rotary mechanism albeit in an effort to synthesis ATP from ADP and
inorganic phosphate [53,54]. Similar to that of the ATP synthase, ATP hydrolysis and
the translocation of protons by the V-ATPase are both initiated by conformational
changes within the A3B3 complex. The catalytic complex is composed of a pseudotrimer of alternating A and B subunits with each subunit having a unique conformation
according to the nucleotide-binding state of the catalytic A subunit. ATP binding sites
are located near the subunit interfaces, but only the A subunits have catalytic activity,
whereas the B subunits bind ATP but are non-catalytic [55,56,57,58] (Figure 1.5). Each
AB pair is arranged into one of three conformational states. An open conformation
corresponds to an empty state with no nucleotide bound to subunit A. A loose
conformation describes an ADP-bound state, and a tight conformation relates to the
ATP-bound state [11]. Cycling between these conformations drives the rotation of the
central rotor ultimately resulting in the translocation of protons across the membrane
[59].
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Figure 1.5 The nucleotide-binding sites of the prokaryotic V-ATPase. (A) The catalytic
sites of the A subunits (green) are indicated by red circles and the non-catalytic
interfaces on the B subunits (yellow) are illustrated by blue circles. (B) The subunit
interface between the ATP-bound A and B subunits (AN and BN). The side chain of
Arg360 on subunit B is shown by superposition of the F1-ATPase structure [60]. (C) The
ADP-bound AB interface (AN’ and BN’). (D) The empty-state AB interface (AW and BW).
Figure Adapted from Numoto et al, 2009 [61].
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1.2.3 ATP-UTILIZING PROTEIN FOLDING MACHINES
Chaperonins are large, multi-subunit assemblies that function by mediating the
ATP-dependent protein folding of nascent polypeptides into their native state. The role
of chaperonins is to provide kinetic assistance, through the utilization of ATP, to “edit”
the folding process and thus prevent or reverse protein misfolding that can lead to
irreversible protein aggregation [62]. As a result of their omniscient function in a variety
of cellular compartments, the chaperonin machinery operates beyond the machineries
of transcription and translation to bridge the final gap between DNA and biologically
active protein [62].
The chaperonin ring structures are unique among the family of molecular
chaperones in that they utilize the energy derived from ATP hydrolysis to undergo large
conformational changes that guide substrate proteins along a refined folding pathway
within a well-sequestered and encapsulated environment [63]. The chaperoninmediated process appears to be an all-or-nothing event in which a time-limited attempt
at folding within the encapsulated environment is followed by the release of the
polypeptide into the bulk solution even prior to the substrate reaching its native state
[64]. As a result, partially folded proteins likely encounter multiple rounds of chaperonin
encapsulation and folding. Interestingly the iterative folding process has been regarded
as an energetically inexpensive event in that the complete folding of nascent
polypeptides requires approximately 10% the amount of ATP as used in the translation
process [65].
The general architecture of chaperonins consists of the back-back stacking of
homo or hetero oligomers each containing seven to nine individual subunits [66,67,68]
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(Figure 1.6A). Each subunit is organized into separate equatorial, intermediate and
apical domains that each execute distinct functions respectively [69,70,71,72] (Figure
1.6B). Of particular interest, the equatorials domain house the ATP binding pockets and
are responsible for maintaining the inter-ring contacts [73,74,75] (Figure 1.6C).
Additionally the intermediate domains tether the equatorial and apical domains together
as the apical domain are responsible for interacting with both the unfolded substrate
protein and a co-chaperonin, if required [76]. The large conformation flexibility of the
apical domains contributes to the opening and closing of the ring cavity [75].

Figure 1.6 The architecture of the ATP-bound GroEL chaperonin from E. coli (PDB
2C7E) [77]. (A) A side view of the overall structure of GroEL highlighted by the ATPbound and active folding cis ring (single monomer in red, ATP in yellow) and the
inactive trans ring (single monomer in blue). (B) The apical (green), intermediate (blue)
and equatorial (red) domains of an individual GroEL subunit. (C) Close up view of the βα-β-α-β (β-sheets and α-helices are depicted in blue and red respectively) motif cradling
ATP (yellow) and a magnesium molecule (green) within the equatorial domain of a
single GroEL subunit.
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All chaperonins can be characterized as molecular ATPases based on a
universal requirement for ATP and the energy derived from its hydrolysis to drive the
protein folding mechanism [78]. However, chaperonins are be classified as either type I
or II based on their individual requirements of a co-chaperonin [79] (Figure 1.7). Type I
chaperonins employ a detachable lid-like co-chaperone structure that binds in an ATPdependent fashion. Type II chaperonins make use of a built-in structure that can
protrude upward during the substrate-accepting state and then retracts into a closed
conformation upon ATP binding, producing an active-folding, encapsulated state
[74,80,81,82]. Despite the different encapsulation mechanisms, the role that ATP plays
in the type I and II chaperonins appears to similar in that ATP hydrolysis is directed by
identical ATP-binding motifs within the equatorial domains [62].

Figure 1.7 Structural differences between type I and II chaperonins. Type I chaperonins
like the homooligomeric GroEL/ES, require a co-chaperonin to assist a two stroke
protein folding mechanism [83,84]. On the contrary, type II chaperonins like the
heteromeric (two separate subunits are outlines in green and cyan) thermosome, do not
utilize a co-chaperone in their cooperative binding mechanism [85,86].
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Of all chaperonins, the type I bacterial GroEL/ES has been the most extensively
studied chaperonin system and serves as the basis from which the general mechanism
of chaperonin-mediated protein folding was first elucidated [79,87,88]. In the GroEL/ES
system, there is a positive cooperativity of intra-ring ATP binding within each ring by
way of a concerted mechanism. This occurs in conjunction with the negatively
cooperative and sequential inter-ring binding of ATP [84,89] (Figure 1.8). The
mechanism begins with a nascent or misfolded protein having a high affinity for the
chaperonin in the ATP-bound conformation [90]. In this form the apical domains line the
opening of the central cavity and attract binding of the substrate through hydrophobic
interactions with exposed hydrophobic residues [78,88,91]. Upon binding of ATP to the
seven subunits of one GroEL ring, the complex is primed to accept the GroES cochaperonin as these two events collectively induce a conformational change within the
apical domains that switch the internal ring environment from hydrophobic to hydrophilic
[62,88]. This sequesters the substrate within a hydrophilic cis ring cavity where viable
protein folding is isolated and is thermodynamically favorable [91]. Folding continues in
the cis cavity for the longest phase of the mechanistic cycle, approximately 10 seconds,
upon which ATP is hydrolyzed within the equatorial domains of the cis ring weakening
its affinity for GroES [92]. Concurrently ATP enters into the binding sites of the trans ring
[92]. Binding of ATP to the trans ring sends an allosteric signal that ejects the cis ring
contents (co-chaperonin, partially or fully folded protein product, and ADP) while
simultaneously converting the once trans ring into the cis conformation [92,93,94]. As a
result, the two rings switch back and forth between the cis and trans conformations to
employ a highly efficient protein folding operation that is tightly regulated by ATP [84].
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Figure 1.8 The GroEL ATPase cycle. The hydrolytic reaction is divided into two phases.
The first phase illustrated the pre-steady-state behavior of unbound GroEL when first
mixed with ATP and the GroES co-chaperone. The apo-GroEL cis ring fills
cooperatively with 7 molecules of ATP and the newly bound chaperonin readily
encapsulates substrate protein (red), followed by the rapid binding of GroES [95,96].
The resulting GroEL-ATP-GroES complex hydrolyzes the ATP with an intrinsic turnover
rate of 0.12 s-1 [97]. Sequentially the binding of ATP to the open trans ring, initiates the
disassembly of the cis complex, leading to the release of GroES, ADP and the folded
protein product (green) [92,93,98]. The steady-state cycling of the ATP- and ADP-bound
conformations between the two negatively cooperative rings constitute the second
phase of the nucleotide-driven mechanism. In vivo the GroEL-GroES system persists
almost exclusively within phase II [99,100]. This figure was adapted from Madan et al,
2008 [99].
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1.2.4 AMINOACYLATION: ENERGETICALLY EXPENSIVE BUT IMPORTANT
The viable synthesis of protein in synch with the information specified in its
mRNA sequence requires a tremendous amount of cellular energy [101]. For example,
in the first stage of protein synthesis, aminoacyl-tRNA synthetases (aaRS) catalyze the
esterification of the 20 amino acids to their respective tRNAs [102]. The formation of
each aminoacyl-tRNA requires the energy derived from the hydrolysis of one ATP
molecule during the formation of aminoacyl adenylate (aminoacyl-AMP) [103].
Additionally a second ATP molecule can be consumed each time an incorrectly
activated amino acid amino acid is hydrolyzed by the proof reading activity of its
respective aminoacyl-tRNA synthetase [103,104]. Furthermore, GTP is required to fuel
the initiation and elongation steps of ribosome-mediated protein synthesis as well as the
final translocation of the nascent polypeptide from the ribosome complex [105,106,107].
This exceedingly large thermodynamic “push” in the direction of protein synthesis
epitomizes the biological need for peptide bond formation to occur unambiguously
between two specified amino acids as proteins are information-containing polymers
representative of both the DNA and RNA genetic codes [108,109].
As previously mentioned, aaRSs are responsible for the specific aminoacylation
of transfer RNAs [110]. For the 20 individual amino acids there is a designated aaRS
that catalyzes the respective aminoacylation reaction through a two-step mechanism
that requires the use of ATP, amino acid and tRNA substrates [110,111,112,113]
(Figure 1.9A). In the first step, the enzyme-bound intermediate aminoacyl-AMP is
formed when the carboxyl group of the respective amino acid reacts with the αphosphoryl group of ATP to form an anhydride linkage [114]. This reaction occurs in the

15

presence of magnesium ions and results in the displacement of pyrophosphate which is
later hydrolyzed into free phosphate. As a result, the overall amino acid activation
process is rendered thermodynamically irreversible (∆G’°= -29kJ/mol) [115,116]. In the
second step, the aminoacyl group is transferred from the aaRS-bound aminoacyl-AMP
to the designated tRNA for initial integration into the ribosome complex [102,117]. The
final aminoacylation of tRNA can ultimately result in two distinct scenarios: the amino
acid can be primed for peptide bond formation or can be attached to an adaptor tRNA
that ensures the appropriate placement of the amino acid in the growing polypeptide
chain [103,114]. This form of proofreading is energetically costly but is absolutely
essential for viable protein synthesis as the fidelity of the respective aminoacylation
reactions is not checked by the ribosome prior to translation [105].
The architecture supporting the ATPase activity of aaRSs has been elucidated in
a number of prokaryotic and eukaryotic systems [118,119,120,121,122]. Interestingly
the structural homology within the ATP-binding domains of the 20 different aaRS
enzymes is limited giving rise to the separation of the respective aaRSs into two
separate classes. In the active sites of class I aaRSs, ATP adopts an extended
conformation reminiscent of that found in other proteins containing a Rossmann fold
[29]. In the case of GlnRS, Arg260 provides a charge balance to the β-phosphate
through a water molecule while Lys270 interacts with α- and γ-phosphates [123,124]. In
class II active sites as observed in SerRS, ATP exhibits a compact conformation in
which the γ-phosphate folds back over the adenine base [121] (Figure1.9B-C). In both
classes the binding of ATP is stabilized by the bridging of Mg2+ ions between the β- and
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γ-phosphates [121]. In doing so, Mg2+ withdraws electrons from the β-phosphate and
thus assists the catalytic function of the aaRS [124].

Figure 1.9 Aminoacylation of tRNA by aminoacyl-tRNA synthetases. (A) The resulting
ester linkage between the amino acid and the tRNA requires the hydrolysis of ATP at
the α-β phosphoanhydride bond and has a highly negative standard free energy of
hydrolysis (∆G’°= -29kJ/mol) [115,116]. Figure adapted from Ferrer, 2006 [125]. (B) The
crystal structure of the ATP-bound seryl-tRNA synthetase from Trypanosoma brucei
(PDB 3LSS). The α-helix and β-sheet secondary structural elements (red and yellow,
respectively) surrounding the nucleotide-binding pocket (ATP-blue). (C) Close-up view
of the anti-parallel β-sheet cradling the compact conformation of ATP [29].
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CHAPTER 2
METHODOLOGIES OF STRUCTURAL AND MOLECULAR BIOCHEMISTRY
2.1

INTRODUCTION
In 1934 J.D. Bernal and Dorothy Hodgkin became the first to discover X-ray

diffraction from protein crystals [126]. It was found that the sharp reflections extended in
relation to finite inter-atomic plane distances, indicating that pepsin was not arbitrarily
organized by random coils but rather that the three-dimensional structure was arranged
by approximately 5,000 atoms occupying definitive orientations in a crystalline array
[127]. This discovery provided a fundamental biophysical understanding that has served
as the foundation for the study of structural biology. For instance Max Perutz and Sir
John Kendrew became the first the resolve an atomic protein structure which resulted in
being awarded the Nobel Prize in Chemistry in 1962 [128,129]. As a result of the early
works of biophysicists like J.D Bernal and Max Perutz precedence was set for the
mainstream practice of protein X-ray crystallography that has now resulted in the
structural investigation and elucidation of nearly 49,000 structures of proteins, nucleic
acids and other biological molecules to atomic resolution [127,128,129,130] . In addition
to X-ray crystallography, Nuclear Magnetic Resonance spectroscopy (NMR) also carries
the capability of resolving atomic structural details but is of limited use for the structural
investigation of proteins due to size restrictions that do not warrant resolvable data
outside of the range of peptides and small proteins [131,132].
Of particular interest, the development of high-resolution electron microscopy
(EM) techniques has made EM an effective tool in the analysis of macromolecular
assemblies [133,134] including viruses [135,136], proton pumps [137,138], ribosomes
[139,140], molecular chaperones [141] and protein microtubules [142]. Interestingly the
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quality of EM reconstructions has now reached atomic resolution in some highlysymmetrical proteins as is evidence by a recent 3.6Å reconstruction of the human
adenovirus [143]. Recent improvements achieved in the resolution of EM
reconstructions are attributed to a number of factors including the emergence of cryobased sample preparations, more advanced microscope specifications, highly refined
data processing algorithms and parallelized computer clusters [144]. For example the
development of cryo-electron microscopy (cryo-EM) has allowed biological samples to
be flash frozen in liquid ethane and maintained under under-liquid nitrogen
temperatures (-180°C) as a thin layer of vitrified ice [145]. This allows for the respective
sample particles to be analyzed in an aqueous state that does not require a denaturing
heavy metal/salt solution for differentiation of individual particles [146,147]. Additionally
the use of microscopes with field emission guns (FEG) provide a brighter and more
coherent beam that results in less image aberrations [144]. Furthermore, robust
software suites have been developed to process large data sets where more than 105
individual particles can be incorporated into a single particle reconstruction to reach
near-atomic resolution [134,148]. In general, EM analysis has become a very powerful
tool in deciphering protein folding mechanisms [149,150,151], protein synthesis
dynamics [152,153] and viral infection pathways [143,154]. EM structural investigations
have helped further our understanding of the relationship between structure and
function as the mechanistic activity/catalysis of protein molecules can be explained by
its atomic architecture.
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2.2

PROTEIN EXPRESSION AND PURIFICATION

2.2.1 BACTERIAL EXPRESSION OF RECOMBINANT CONSTRUCTS
All successful structural and/or biochemical investigations begin with the
acquisition of large quantities of highly purified sample. In many cases this requires the
use of recombinant DNA technologies due to the vast number of regulations that govern
the collection of specimens from higher-eukaryotic sources. Using recombinant
technologies, DNA can be synthetically constructed to encode for any sequence-based
gene in which the target gene can be amplified through the polymerase chain reaction
(PCR) [155,156]. Furthermore the gene of interest can be ligated into a circular piece of
DNA known as an expression plasmid for transformation into a host organism that can
be induced into protein translation of the recombinant gene [157,158]. To date one of
the most widely utilized expression vector system is the pET system that was developed
for the cloning and expression of recombinant proteins in E. coli [159]. Once
transformed into genetically modified E. coli containing a copy of the T7 polymerase
gene (BL21 DE3), the expression of recombinant target protein is modulated by a T7lac
promoter that is highly specific for viral phage T7 RNA polymerase [160,161,162].
Incorporation of lactose induces the expression of T7 RNA polymerase from the
bacterial genome that ultimately results in expression of the target gene (Figure 2.1).
Bacterial expression of recombinant proteins is generally very effective resulting in
upwards of 100mg of target protein being expressed in 1 L of media culture grown
[163]. However in some cases the expression of target gene products can become toxic
to the host cells and the activity of the T7 RNA polymerase must be tightly regulated
[159]. This can be accomplished by controlling the concentration of the inducing agent
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where limited levels of recombinant protein expression may attenuate the stress
endured by the host cells [161]. Alternatively, E. coli expression cells that carry the gene
for the bifunctional T7 lysozyme protein (BL21 DE3LysS) can be used to control the
expression yield of target protein. This form of regulation is the result of the T7
lysozyme simultaneously hydrolyzes the peptidoglycan layer of the bacterial cell wall as
well as inhibiting T7 RNA polymerase-mediated transcription [164,165,166,167,168].
It is worth noting that in some cases the expression of highly hydrophobic or
misfolded proteins can lead to aggregation or inclusion body formation in the cytosol. As
a result, chaotropic agents and chaperone proteins must be used for the unfolding and
proper refolding of the target protein. Additionally problems with protein solubility can be
circumvented by manipulating the incubation temperature during protein induction
and/or by incorporating a membrane localization signal into the initial recombinant
construct that will direct the nascent polypeptide into the cytoplasmic membrane
[169,170]. In doing so the polypeptide will be sequestered in a membranous
environment where proper folding can occur [169,170,171].

Figure 2.1 Regulation of the T7lac promoter. Adapted from the pET Manual [159].
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2.2.2 PROTEIN EXTRACTION
Once the expression conditions for the recombinant protein have been optimized,
the target protein can be extracted from the host cells through a number of variable
procedures. Sonication, high-pressure homogenization, freeze/thaw cycling and osmotic
shock can be used to mechanically lyse bacterial cells, however the crude force of
these techniques generally initiates the activity of proteases and enzyme-inhibiting free
radicals [172]. Of the aforementioned techniques, freeze/thaw cycling is the most gentle
procedure where ice crystal formation during the freezing process perforates the
bacterial membranes and cell wall [173]. Bacterial cells can also be chemically lysed
when treated with EDTA and lysozyme. EDTA is a chelating agent that sequesters
divalent cations. When added to bacterial cells, the loss of Mg2+ and Ca2+ ions from the
cells walls ultimately results in the release of periplasmic proteins due to the loss of the
semi-permeable barrier [174]. In conjunction with EDTA, lysozyme can be added to
hydrolyze the β1-4 glycosidic linkages in the peptidoglycan of the bacterial cells walls
for access and harvesting of the cytoplasmic contents [175,176]. Additionally detergents
can be used to extract membrane proteins from the cytoplasmic and periplasmic
membranes as well as to enhance the solubility of highly hydrophobic recombinant gene
products expressed in the cytoplasm [174].
2.2.3 HIGH-PERFORMANCE LIQUID CHROMATOGRAPHY
The chromatographic separation of proteins is based on a number of chemical
and physical interactions that can occur between the solute of interest and the
separation matrix (Figure 2.2) [177]. The main attractive forces that draw protein
molecules to bind with stationary matrices include hydrophobic, electrostatic, and
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electron donor-acceptor interactions where reverse-phase, ion-exchange and affinity
chromatographies are used, respectively [178]. Additionally proteins can be separated
based on their molecular size by using size-exclusion chromatography [177].

Figure 2.2 Schematic diagram of an HPLC system. The sample is injected into the
packed column (**) that is loaded with a stationary matrix material characteristic to the
type of chromatography being performed. Protein elutions from the column are recorded
by UV detection (280nm) and are fractionated into separate collections to isolate the
individual chromatographic peaks. Quantitative analysis of each individual fraction is
then performed by SDS-PAGE. Image is courtesy of the Protein Facility of the Iowa
State University Office of Biotechnology.
Reverse-phase (also termed hydrophobic interaction) chromatography is a
separation technique that immobilizes proteins by way of hydrophobic patch interactions
with a non-polar, phenyl-based column absorbent [179,180]. Using this technique, the
sample is loaded onto the column in conjunction with a high salt buffer (~1.5-2.0M
ammonium sulfate) that is required to enhance of surface area for any potential
hydrophobic interactions. It is assumed that the solvation layer is displaced between the
hydrophobic matrix ligand and the interacting hydrophobic patch of the protein as a
result of the increased entropy at the interface [181]. Once bound the respective
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protein(s) can be eluted from the column with salt-free buffer which negates the
aforementioned interactions by restoring the solvation layer surrounding the phenylbased matrix ligands [182].
Ion-exchange chromatography is one of the most widely used techniques for the
separation of proteins on the basis of surface charge and Coulombic interactions
(Figure 2.3A) [177]. Charged R-groups on the external surface of proteins act as binding
surfaces for potential interactions with the oppositely charged groups of the stationary
matrix [183]. For example, proteins rich in lysine, arginine and histidine residues are
likely positively charged at physiological pH and would bind strongly to the negatively
charged, sulfonate-based matrix of a cation-exchanger. Conversely, proteins rich in
aspartic and glutamic acids residues would likely be negatively charged at physiological
pH and would bind strongly to the positively charged, ammonium-based matrix of an
anion-exchanger. The phenomenon of proton and charge donation is illustrated by the
Henderson-Hasselbalch equation which explains how the charge of a given protein’s
amino termini and positively charged R-groups (HA) and carboxy termini and negatively
charged R-groups (A-) are a function of the isoelectric point (pI) of the protein and pH of
the buffering solution [184].
Equation 2.1

pH = pI + log[A-]/[HA]

In ion-exchange chromatography immobilized proteins are eluted from the
column by increasing the ionic strength of the eluent [185]. Additionally the target
proteins can be eluted with a pH gradient that would alter the overall charge on the
surface of the proteins thus manipulating the strength of the Coulombic interactions with
matrix [186].
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Affinity chromatography is a highly selective method for binding of target proteins
to a support matrix based on the utilization of a substrate’s biological affinity for a
particular ligand (Figure 2.3B) [187]. For example electron-rich residues such as
histidine, tryptophan, tyrosine and phenylalanine can act as electron donors when
presented on the surface of proteins and can interact with electron acceptors like
transition metals [188]. Different metal ions have different affinities for different protein
residues but generally the binding strength increases in the order of Ca2+ < Co2+ < Ni2+
< Zn2+ < Cu2+ [189]. Of particular interest, histidine residues have an affinity for Ni2+ and
Co2+ ions and can form coordination complexes with transition metal-based columns in
which the metal ions are immobilized by a chelating agent like nitrilotriacetic acid
[177,190]. For this reason, it is possible with recombinant DNA technology to produce a
target protein with a hexa- or deca-histidine affinity tag region that will coordinate with
the stationary matrix of a nickel-nitriloacetic acid (Ni-NTA) column [191,192,193]. Once
tagged protein has been isolated away from the cytoplasmic milieu it can be eluted from
the column with the histidine analog imidazole, or through use of a chelating agent like
EDTA.
Size-exclusive chromatography is a versatile method of separation that can be
utilized for a number of functions including buffer exchange, the removal of non-protein
contaminants (DNA, viruses) and aggregates, as well as for the study of proteinsubstrate interactions and protein folding kinetics [194,195,196,197,198,199,200].
Unlike other chromatographic procedures, size-exclusion chromatography is not an
absorption technique but is the result of particle migration through a solid phase matrix
of porous beads (Figure 2.3C) [201,202]. Large proteins that are too large to enter the
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pores of the beads (100-250µm) ultimately have an unimpeded flow path through the
column and as a result elute early in the chromatographic separation. On the contrary,
small proteins that enter the pores of the beads are retained longer and therefore pass
more slowly through the column volume [201]. Through this mechanism, size-exclusion
chromatography is able to separate proteins on the basis of molecular weight and
tertiary structure making it well suited for the elucidation of protein oligomerization
dynamics and protein-binding interactions [203,204,205].

Figure 2.3 Absorption and migration schemes of ion-exchange (A), affinity (B) and sizeexclusion (C) chromatography. Adapted from Lehninger Principles of Biochemistry, 4th
Edition [1].
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2.3

TRANSMISSION ELECTRON MICROSCOPY

2.3.1 INSTRUMENTATION
The anatomy of the modern Transmission Electron Microscope (TEM) is
comprised of a complex arrangement of mechanics, optics and electronics. These
include: a high voltage source, a tungsten/LaB6-tipped filament electron emission
source or FEG, an electron accelerator, gun tilt and translate coils, condenser lenses
with respective aperture and stigmator, beam tilt and translate coils, objective lens and
stigmator, goniometer for tilting the mechanical stage and sample in the x, y and z
directions, coils to electronically shift the image, a series of magnifying projector lenses
and respective beam deflector coils, a viewing chamber equipped with a fluorescent
screen to convert electrons to visible light, binoculars and a film and/or charge-coupled
device (CCD) camera (Figure 2.4A) [206,207]. Additionally the TEM can be equipped
with a variety of energy filters and apertures that can each significantly decrease the
occurrence of second- and third order aberrations by blocking the transmission of
inelastic scattering electrons with weaker and heterogeneous intensities [208,209,210].
The functionality of the TEM begins with an accelerating voltage that is applied to
the cathode cap (Wehnelt cylinder) and then to the emission filament (Figure 2.4B)
[211]. Under the control of a bias resistor, the Wehnelt cylinder becomes slightly more
negative than the filament allowing for an electron cloud to collect inside the cap. An
anode located below the gun assembly creates an attraction for the negatively charged
electrons resulting in their acceleration through the small hole in the anode [212]. Next
the electron beam is manipulated by a series of electromagnetic convergent lenses that
are comprised of conductive wires surrounded by a metal shroud [206]. As electrons
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pass through the center pole piece of each lens solenoid they become further
constricted and concerted (Figure 2.4C).
The electron beam initially passes through the condenser lenses that gathers the
electrons from the first crossover image and concentrates them onto the specimen. A
condenser aperture filters out unwanted divergent electrons while the condenser
stigmator adjusts for any beam astigmatism [213]. Next the beam travels through the
objective lens, near which the sample is inserted. The objective lens focuses and
initially magnifies the image which is also done by the projector lens near the base of
the microscope [212].
The entire instrument is maintained under a vacuum typically in the order of 10-7
to 10-9 Pa to reduce the collision frequency of electrons with gas atoms, as well as to
account for the voltage difference between the Wehnelt cap and the ground. This
prevents any damage to the cathode from any potential electrical discharge [214,215].
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Figure 2.4 Schematic diagram of a transmission electron microscope. (A) Basic
anatomy of a TEM. (B) The structure of the emission filament in relation to the Wehnelt
cylinder and the acceleration anode. (C) The influence of the electromagnetic lenses on
the trajectory of the electron beam. Adapted from the University of Iowa’s Center for
Microscopic Analysis.
2.3.2 SPECIMEN PREPARATION
Cryo-EM has recently become the most ubiquitous technique in the TEM
structural analysis of biological macromolecules. This is largely in part due to the fact
that samples can be preserved in a native or near-native state [216,217]. Other
methods such as chemical fixation and negative straining can perturb the native
structure of samples [218,219]. For example, negative staining, in which a heavy metal
salt creates an envelope encasing the sample particles, can result in a varied degree of
sample flattening or dehydrogenation which can affect the resolution of the final
reconstruction [220]. Such artifacts can be negated by incorporating sugars such as
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trehelose into the staining solution [221] or can avoided all together by vitrifying the
sample in the near-native state using cryo-EM.
The acquisition of a high-quality cryo-EM data set begins with the vitrification of a
highly homogeneous sample. To begin, a small 2-4µl sample aliquot is loaded onto a
copper grid that has been coated with a holely carbon film [144]. The sample drop is
blotted with filter paper leaving a very thin layer of solution suspended in the holes of
the carbon film. Immediately the grid is plunged into a volume of liquid ethane where the
cooling rate of the sample exceeds 106 °C/s resulting in vitreous ‘glass-like’ ice
formation [145]. To date, plunge freezing can be performed in automated systems
where the preparation of cryo samples maintained in thin vitreous ice is achieved with
consistency and precision [222].
The thickness of the ice in a cryo sample preparation is of paramount importance
as water molecules within the vitreous ice can scatter electrons, adding noise and the
EM images [144]. Additionally the prevalence of thick or crystalline ice can significantly
decrease the contrast and resolution in the EM images [133].It is worth noting that the
electron microscope is maintained at near-liquid-nitrogen temperature during data
collection to prevent the formation of crystalline ice as well as to reduce specimen
damage caused by the electron radiation (10-40 e/Å2) [219]. Furthermore, data
collection in the cryo-electron microscope at -170°C ultimately results in a higher signalto-noise ratio than regular EM by allowing for 9 to 22 times the election radiation
compared to data collection at room temperature [223].
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2.3.3 SINGLE PARTICLE RECONSTRUCTION
The general process of reconstructing a three-dimensional model from twodimensional cryo-EM images requires a number of steps beginning with the acquisition
of high-resolution images (Figure 2.5). Particles in presumably random orientations are
selected and extracted from the EM micrographs to be used for information regarding
the entire particle density in projection [144]. The selected particles are centered and
normalized to account for any differences in ice thickness and electron dose. If left
unaccounted for these factors can lead to a variable distribution of optical density
between different micrographs or between different areas within a single micrograph
[219]. Additionally the isolated particles are processed with their respective defocus
values and are contrast transfer function (CTF) corrected prior to being incorporated
into a reconstruction (see section 2.3.4). Next the individual particles are classified into
groups (class averages) based on their orientation and origin in relation to the complete
three-dimensional structure using multivariate statistical analysis (MSA). If an initial
model is available it can be derived into reference projections that are arranged into a
library of 2D images based on angular spacing [224,225]. The class averages of the
individual particle are then created and refined against the reference projections as a
function of various alignment parameters such as shifts/translations and angular
rotation, oh which can be refined iteratively [148,224]. After refinement, the mostrepresentative class averages serve as references for the individual particles that
become incorporated into an initial three-dimensional map. Iterative refinement of the
EM map is performed against a number of parameters such as band pass cutoff
(resolution filtering), radial filtering and imposed symmetry until the resolution of the final
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reconstruction has converged [148,226]. The resolution of the final reconstruction can
be estimated by splitting the data set into two and generating two independent
reconstructions for comparison. A Fourier shell correlation is then used to measure the
correlation between the Fourier coefficients of the two reconstructions, as a function of
the resolution shells [227,228]. Additionally the validity of the final EM reconstruction
can be verified upon docking X-ray coordinates of relevant structures into the EM
density and measuring the degree of average value of density at all atomic positions
[229].

Figure 2.5 A flow chart diagram summarizing the key steps involved in single particle
analysis, image processing and development of a three-dimensional reconstruction.
Adapted from Ruprecht and Nield, 2001 [230]
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2.3.4 ALGORITHMS OF IMAGE PROCESSING
The contrast seen in TEM micrographs is a function of amplitude (scattering) and
phase (interference) contrasts that result from electron scattering [231,232]. Amplitude
contrast relates to the degree of scattering of the atoms in the sample. For example it is
known that heavy atoms like gold have a stronger amplitude contrast than do light
atoms such as nitrogen [233]. Phase contrast arises from the interference between the
elastic and inelastic electron beams and depends on the relative focus condition during
recording of the micrograph [144]. Cryo-prepared biological samples are generally
composed of light atoms such as carbon, hydrogen, nitrogen, oxygen and sulfur, all of
which have low amplitude contrast [232]. To compensate, cryo-EM images are taken
slightly under-focus to increase the phase contrast of the individual particles in the
micrograph [234].
The relationship between the image of the specimen and the specimen itself is a
function of the relative degree of under-focus and the imperfections of the microscope
lenses that contribute to the point spread function of the collected image [133,235]. This
can also be defined as the impulse response of the microscope to a point source or
object. Collectively the image conditions can be approximated mathematically by the
CTF as a function in Fourier space involving both the amplitude and phase contrast
components (Equation 2.2) [133,223].
Equation 2.2

CTF(ν) = - {(1-F2amp)1/2 · sin(x(ν)) + Famp · cos(x(v))}

Where x(ν) = π · λ · ν2(Δf – 0.5 · Cs · λ2 ν2), ν is the spatial frequency per angstrom,
Famp is the contrast amplitude, λ is the electron wavelength (Å), ν is the acceleration
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voltage of the electron beam, Δf is the under focus value (µm) and Cs is the spherical
aberration of the objective lens, the CTF can be simplified to:
Equation 2.3

CTF’(ν) = CTF(ν) · exp(-(δν)2)

where δ is a decay factor describing the attenuation of the amplitude in relation to
increasing resolution (Figure 2.6) [144,236,237]. CTF corrections such as phase flipping
and Wiener filtering must be applied to all cryo-EM images before incorporating them
into the working data set in order to achieve a reliable representation of the structure
[148,235].
It is worth noting that in Fourier space the phases of the image are flipped when
the CTF passes through zero. The structural information about the object is lost at each
zero, but can be recovered by sampling data at different defocus values (Figure 2.6).
Generally images are collected throughout a range of defocus values (typically 0.8-2.0
µm) to ensure that data is present in all regions of the CTF [133,219,238].

Figure 2.6 A CTF plotted as a function of resolution (Å) for images with defocus values
of 0.1 µm and 2.0 µm respectively. Image from Baker et al, 1999 [133].
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2.3.5 ALGORITHMS OF A SINGLE PARTICLE RECONSTRUCTION
In order to determine the orientations and origins of the CTF corrected particles,
a series of projection matching algorithms are applied to compare the 2D image of each
particle to a database of 2D projections of various particle orientations [236,239]. Each
particle orientation is determined by the best correlated projection defined by the
rotation angles Θ,Φ and Ω [239]. The origin of each particle is resolved by translating
the image along the X and Y Cartesian axes of the 2D image [240].
Once the orientations and origins of all the particles are determined, the
projection theorem can be used to reconstruct a 3D model [144]. The projection
theorem stipulates that a central section Q(X,Y,0) of the Fourier transform Q(X,Y,Z) of
the 3D object φ(x,y,z) is equal to the Fourier transform of a projection φ(x,y) of the 3D
object in a certain direction [219,241,242] (Equation 2.4). Synonymously, the projection
theorem explains how the projection of an object taken at a given angle is equal to the
Fourier transform of the multidimensional object at the respective angle.
Equation 2.4

Q(X,Y,Z) = ʃʃʃ φ(x,y,z)e2πi(xX+yY+zZ)dxdydz
Q(X,Y,0) = ʃʃʃ φ(x,y,z)e2πi(xX+yY)dxdydz
= ʃʃ(ʃ φ((x,y,z)dz)e2πi(xX+yY)dxdy)
= ʃʃ φ(x,y)e2πi(xX+yY)dxdy

If enough sections from the Fourier transform of particles with well-distributed directions
are collected, an inverse transform can be performed on the fully occupied 3D Fourier
space to yield the 3D density in real space [242,243]. Under ideal conditions, the
number of projections (n) needed to achieve a desired resolution (d) is defined by:
Equation 2.5

n = (π · D)/(d ·Nsym)
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where D and Nsym are the diameter and symmetry of the 3D object, respectively [242].
2.4

BIOCHEMICAL ANALYSES
As seen in many structural investigations, biochemical analyses can be used to

corroborate structural findings in addition to further illustrating functional roles played by
the macromolecule under investigation. For example in a recent communication to
Nature regarding the 3.5Å crystal structure of the carnitine/butyrobetaine antiporter from
Proteus mirabilis, proteoliposome-based scintillation and fluorescence
spectrophotometry experiments were conducted to support the structural details of the
atomic model [244]. Additionally, techniques such as dynamic light scattering (DLS), coimmunoprecipitation (co-IP) and Native polyacrylamide gel electrophoresis (NativePAGE) can also be used to highlight the relationship between structure and function as
well as revealing any mechanistic protein-protein or protein-ligand interactions
[245,246].
2.4.1 DYNAMIC LIGHT SCATTERING
DLS is a method of monitoring the temporal behavior of scattered light in which
the apparent diffusion coefficient (Dapp) can be directly related to the size distribution
profile of small particles in suspension [247,248]. This technique utilizes a
monochromatic laser that is directed towards a solution of particles in Brownian motion
(Figure 2.7) [249]. Photon diffraction from spherical particles cause a Doppler shift that
is detected by a photomultiplier that transforms the variable light intensities into voltages
through the Wiener-Khintchine theorem [249,250]. Quantitative data of the particles in
solution is derived from an autocorrelation function of the data processed by the
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photomultiplier where a probability density function calculates the diffusion constant (D)
assuming Brownian motion (Equation 2.6) [251,252,253].
Equation 2.6

P(r,t|0,0)=(4πDt)-3/2 exp(-r2/4Dt)

Assuming that the particles in solution are spherical in shape, the diffusion
coefficient can be derived to yield the radius of the particles using the Stoke-Einstein
relation (equation 2.7) [254]. In this case the particle radius (a) is related to the viscosity
of the solvent (η), temperature in Kelvin degrees (T) and the Boltzmann constant (kB).
Equation 2.7

D=kBT/6πηa

Figure 2.7 A cartoon schematic diagram of how scattered Doppler waves are correlated
to particle size distribution and polydispersity through the autocorrelation function.
Image was adapted from the Chemical Biology Division at the University of Jyvaskyla,
Finland.
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2.4.2 CO-IMMUNOPRECIPITATION
Immunoglobulins, also known as antibodies, are multimeric Y-shaped protein
assemblies that function as part of the immune system to bind to specific antigens with
extremely high affinity [255]. Antibodies are composed of heavy (Mr 50,000-77,000 Da)
and light (Mr ~25,000 Da) chain fragments that are held in a heterotetrameric formation
by a combination of non-covalent and covalent interchain interactions [256]. The aminoterminal ends of the arm-like Fab domains contain portions of the heavy and light chains
with sequence variability that characterize the antigen specificity of the complete
antibody [257]. Antibodies also contain two heavy chain Fc domains that are separated
from the antigen-binding Fab domains by flexible hinge regions and are responsible for
receptor binding and the catabolic regulation of antigen-bound complexes (Figure 2.8)
[258,259].

Figure 2.8 Domain organization of a IgG immunoglobulin. The amino-terminal ends of
the Fab domains contain the variable heavy and light chain regions (VH and VL
respectively) that comprise the antigen binding site (antigen-green). The second and
third constant regions of the heavy chain (CH2 and CH3) make up the Fc domain. Image
adapted from Caravella et al, 2010 [260]
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Of particular interest, Protein A isolated from bacteria, has a strong binding
affinity (K=108 l/mol) for Fc fragments belonging to the IgG class of immunoglobulins
[261]. When coupled to sepharose beads, antibody-bound protein A can serve as a
medium for the highly specific probing of protein-protein interactions by way of pulldown assays. Through co-IP the formation of protein complexes is analyzed by initially
baiting the antibody-bound protein A beads with the specific protein carrying the
compatible epitope recognition region [245]. As a result, the antibody/protein-bound
beads scavenge protein binding interactions that are specific to the antigen when
subjected to a crude cell lysate or a mixture of proteins in solution [262]. The extent of
the interactions recorded by co-IP can be resolved by SDS- or Native-PAGE.
2.4.3 Native-PAGE
Polyacrylamide gel electrophoresis (PAGE) is a quantitative and qualitative tool
for the assessment of protein samples. Stable protein-protein interactions can be
identified by Native-PAGE in which heat, reducing agents and dissociating detergents
are omitted from the experimental gel matrix and buffering solutions [263]. Through this
technique, protein complexes migrate through the polyacrylamide gel matrix as a
function of their charge to mass ratio with the respective non-covalent and disulfide
bond interactions kept intact [1]. The existence of protein complexes is revealed upon
the addition of Coomassie blue stain to the gel where the negatively charged
triphenylmethane dye binds to amino-termini of the resolved proteins [264,265].
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CHAPTER 3
V1-ATPase PERIPHERAL STALK ARCHITECTURE
3.1

INTRODUCTION
Vacuolar ATPases (V-ATPases) are biological rotary motors that harness the

energy derived from ATP hydrolysis to drive the translocation of protons across a
membrane. These proton pumps generate electrochemical gradients across organelle
and plasma membranes to facilitate a number of secondary transport systems that are
involved in a wide variety of biological processes [266]. For example, eukaryotic VATPases in kidney epithelial cells create an electrochemical gradient responsible for
urinary acidification and the acidification of extracellular spaces that causes bone decay
by osteoclasts [267,268,269,270,271,272] (Figure 3.1). Additionally, plasma membrane
V-ATPases have been found to play a role in sperm maturation and have been
identified in the apical membrane of cells that line the epididymis and vas deferens
where they control the pH of the sperm environment [268]. V-ATPases are also found in
particularly high concentrations in many intracellular compartments such as vacuoles,
endosomes, lysosomes, clathrin-coated vesicles and synaptic vesicles. Here they
assist in receptor-mediated endocytosis, intracellular trafficking, apoptosis, and the
uptake and storage of neurotransmitters, respectively [273,274,275,276,277].
Defects in the human V-ATPase enzyme play a putative role in a number of
pathologies including osteopetrosis, osteoporosis, gastritis, diabetes and metabolic
acidosis [278,279,280,281,282,283]. Interestingly, mutations in the V-ATPase have
been linked to sensorineural deafness, indicating a role the V-ATPase has in
maintaining the pH of the fluid surrounding the mechanosensory hair cells [283].
Additionally, V-ATPases are thought to contribute to the spread of HIV and cancer cell
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metastasis [284,285]. Of particular interest, the method by which tumor cells initiate
cellular invasion requires the secretion of lysosomal enzymes that participate in the
degradation of the extracellular matrix [284]. The activity of these enzymes is greatly
enhanced by an acidic extracellular environment created by the V-ATPase [286].
Recent findings in melanomacytes and breast cancer cells have found these malignant
cell lines to exhibit hypersensitivity and decreased viability when treated with the VATPase inhibitors bafilomycin and phenylsalicylihalamid [287]. These results indicate
that V-ATPase inhibitors could lead to the development of successful anti-cancer agents
if they could be administered in therapeutically-relevant concentrations.

Figure 3.1 The multi-functional V-ATPase. (From left to right) V-ATPases in renal
intercalated cells function in the acidification of urine [267,268,269,270]. V-ATPases in
macrophages and neutrophils function in cytoplasmic pH homeostasis [288]. In
osteoclasts, V-ATPases are essential for bone reabsorption, which requires acidification
of the space that is in contact with the bone [271,272]. Tumor cells also use
extracellular acidification to promote the activity of secreted lysosomal enzymes that
function in metastasis [284,289]. In insect goblet cells, the V-ATPase creates a luminal
positive membrane potential that drives K+ secretion through an electrogenic H+/K+
antiporter which in turn drives the secondary transport of amino acids into the cell
[290,291]. Adapted from Nishi and Forgac, 2002 [286].
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Structurally, the V-ATPase is a large complex comprised of 14 different subunits
arranged into two functional domains; a membrane-bound VO- and a cytosolic V1domain (Table 3.1).
Table 3.1 Characteristics of the V-ATPase subunits. Adapted from Forgac, 2007 [266].

Subunit
(yeast)
V1-domain
A

Molecular
mass
(kDa)

Subunit Function

References

70

[286,292,293]

B

60

C

40

ATP hydrolytic site, regulation via nonhomologous domain, stator subunit
Non-catalytic ATP site, binds actin and
aldolase, stator subunit
Regulatory, stator subunit, binds actin

D
E
F
G

34
33
14
13

Rotary subunit
Stator subunit, binds RAVE
Rotary subunit
Stator subunit, binds RAVE

H
Vo-domain
a

50

Regulatory, stator subunit, binds NEF

100

d

38

e
c
c'
c''
Ac45

9
17
17
21
45

[286,294,295]
[296,297]
[294,298,299,300]
[301,302,303]
[304,305]
[305,306,307]
[304,308]
[294,300,309]
[301,307,310]
[311,312,313]

H+ Transport, targeting, binds aldolase, [286,314,315,316]
stator subunit
[294,317,318]
[319,320,321]
Coupling, rotary subunit
[294,300,322,323]
[301,324,325]
Unknown
[326]
H+ transport, rotary subunit
[286,309]
H+ transport, rotary subunit
[286,327]
H+ transport, rotary subunit
[286]
Unknown
[328]

The hydrophobic VO-domain has a molecular mass of approximately 260 kDa and
is composed of subunits a, c, c', c'' and d in a likely stoichiometry of a(cc')4-5c''d [329].
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The key feature within the Vo-domain is the c, c ', c'' proteolipid ring that contains the
carboxylate residues that are essential for proton translocation [330] (Figure 3.2).
The soluble V1-domain has a molecular mass of approximately 640 kDa and is
composed of eight subunits denoted A-H that are architecturally arranged into subcomplexes according to their distinct roles in the rotary mechanism (Figure 3.2A). For
example, subunits A and B form the A3B3 catalytic complex that is responsible for
hydrolyzing ATP and inducing the rotation of the DF central rotor stalk. Another
important structural component of the V1-ATPase is the stator system constructed of
subunits E, G, C, and H. Subunits E and G constitute the elongated coiled-coil
peripheral stalks that are thought to span the entire length of the B subunits [305,331].
Subunits C and H are found at the V1VO interface and provide a foundation for the
peripheral stalks that stabilize the A3B3 complex against the rotation of the central stalk
[298,311].
ATP hydrolysis and the translocation of protons are both initiated by conformational
changes within the A3B3 complex. The catalytic complex is composed of a pseudotrimer of alternating A and B subunits with each subunit having a unique conformation
according to the nucleotide-binding state of the catalytic A subunit. ATP binding sites
are located near the subunit interfaces, but only the A subunits have catalytic activity,
whereas the B subunits bind ATP but are non-catalytic [55,56,57,58]. Each AB pair is
arranged into one of three conformational states. An open conformation corresponds to
an empty state with no nucleotide bound to subunit A. A loose conformation describes
an ADP-bound state, and a tight conformation relates to the ATP-bound state [11].
Cycling between these conformational states drives the rotation of the asymmetric
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central stalk to create some 35 pN/nm of torque at the cost of one ATP [332]. The
central stalk is composed of a tight hetero-dimeric interaction between subunits D and F
that is attached to the a(cc')4-5c''d proteolipid ring where the two entities move in unison
as the rotor [59]. The final stage of proton translocation occurs when the buried acidic
residues on the proteolipid ring come into contact with subunit a and sequentially bind to
protons in the hemichannel on the cytoplasmic side of the membrane[315]. Upon
rotation of the proton-bound proteolipid ring within the plane of the membrane, the
protons are delivered to the luminal hemichannel interface where arginine residues in
subunit a stabilize the acidic residues of the proteolipid ring in their deprotonated form;
triggering the release protons into the luminal hemichannel [266] (Figure 3.2B).

Figure 3.2 The structure and function of the V-ATPase holoenzyme. (A) The proposed
structure of the complete V-ATPase from yeast. Adapted from Diepholz et al, 2008
[333]. (B) The A and B pseudo-trimers make up the catalytic complex where ATP
hydrolysis occurs. The A3B3 complex is held in place by subunits a, C, H, E and G of the
stator. The catalytic breakdown of ATP drives the rotation of the DF central stalk and
the a(cc')4-5c''d proteolipid ring, ultimately resulting in proton translocation through the
membrane. Adapted from Toei et al, 2010 [334].
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The yeast V-ATPase maintains approximately 25% primary sequence identity with
that of the human V-ATPase, making the yeast V-ATPase a viable model for the
structural and biochemical investigation of V-ATPase function. The architecture of the
yeast V-ATPase has been previously investigated by X-ray scattering [335],
electrospray ionization-mass spectrometry [336], and electron microscopy
[333,337,338,339], revealing the existence of three peripheral stalks. Additionally,
recent work has shown subunits C and H to be positioned at the V1VO-interface
[311,338], where they interact with the three EG peripheral stalk heterodimers
[333,338,340]. Subunits C and H are believed to undergo conformation changes that
play a major role in the regulatory dissociation process of the V-ATPase [333,340,341].
Together these studies indicate that subunits C and H function independently of each
other however, the extent of their interactions at the V1VO-interface has remained
unclear.
In the work presented here, cryo-electron microscopy (cryo-EM) was used to
visualize the yeast V1-ATPase, revealing subunits C and H engaged in a unique
interaction. The CE3G3H reconstruction is highlighted by three distinct peripheral stalk
densities that are stabilized by a CH subunit peripheral stalk base. Furthermore, these
results provide evidence for the possible involvement of subunits C and H in the
formation of a novel sub-complex that can assemble as part of the free V1-ATPase.
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3.2

MATERIALS AND METHODS

3.2.1 SUBUNIT FLAG TAGGING φ
Triple-FLAG epitope tags were inserted at the carboxy-terminus of V-ATPase
subunits by PCR based homologous recombination in the protease deficient yeast
strain c13-ABYS86 [342] using Geneticin resistance as a selectable marker. Colonies
were selected on Geneticin containing YPD agar plates. Single colonies were
transferred into liquid YPD medium and subjected to western blot analysis using antiFLAG antibody (SIGMA). Accessibility of the FLAG tags was assessed by pull down
assays using anti-FLAG antibody coupled agarose beads.
3.2.2 ENZYME PURIFICATION φ
Saccharomyces cerevisiae cells containing a carboxy-terminal 3xFLAG insert
after the sequence for subunit A were cultured on YPD agar plates containing 20 mg/ml
Geneticin. YEP media containing 2% glucose was inoculated with single colonies from
the culture plates and incubated at 30° C. The cells were allowed to grow until the cells
reached mid-log phase growth corresponding to an OD600 between 1 and 5. The cells
were pelleted by centrifugation at 5,018 x g then resuspended in Zymolyase buffer
containing 50 mM Tris-HCl pH 8.0, 10 mM MgCl2, 1 M Sorbitol and 30 mM DTT. After a
second centrifugation step of 5 minutes at 1,500 x g, the cells were resuspended in 3
volumes of Zymolyase buffer. To the suspension, Zymolyase 20T was added and the
sample was shaken at 50 rpm at 30° C for 40 minutes until the cells were converted to
spheroplasts. The spheroplasts were centrifuged at 1,500 x g for 5 minutes at 4° C and
the pellet was resuspended in ice-cold Zymolyase buffer. The spheroplasts were
washed two more times and then lysed by osmotic shock in lysis buffer containing 50

φ

Performed by Ricardo Bernal, Cambridge MRC
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mM Tris pH 8.0, 10 mM MgSO4, 1 mM EDTA, 10 mM potassium acetate, and 1 mM
DTT with a cocktail of protease inhibitors. After a number of freeze/thaw cycles, 5 M
NaCl was added to a final concentration of 100 mM. Anti-FLAG agarose slurry was
added to the supernatant and placed in a disposable BioRad column. After thoroughly
washing to remove unbound protein, the V1-ATPase was eluted with 500 µl elution
buffer consisting of 10 mM Tris-HCl pH 8.0, 2% glucose, 3xFLAG peptide 5 mM ATP
and 5 mM EDTA for a total of 4 elutions. The sample was then concentrated using a
100k cutoff concentrator unit and applied onto a Superose6 size exclusion column
equilibrated with a buffer containing 10 mM Tris-HCl pH 8.0, 5 mM EDTA, 0.1%
glucose, and 5 mM ATP. Sample purity was confirmed by SDS-PAGE.
3.2.3 CRYO-ELECTRON MICROSCOPY φ
The initial sample concentration was diluted from 12.2 mg/ml to 0.75 mg/ml and
blotted onto holey carbon grids before cryogenic plunge freezing. The images were
collected on a FEI F20 transmission electron microscope operating at a voltage of
200,000V. Data was collected on film at 50,000x magnification and under low dose
data collection conditions.
3.2.4 IMAGE PROCESSING AND ANALYSIS
Electron micrographs were scanned and digitized on a Nikon Super CoolScan
9000 ED scanner and binned to an effective pixel size of 2.4 Å. Particles were boxed
using the automated algorithm in the program SIGNATURE [343]. Determination of
defocus was accomplished with the program CTFFIND and Contrast Transform
Function (CTF) correction was performed using CTFIT [344]. An Initial model of the
A3B3DF reconstruction was created using the STARTCSYM command in the EMAN

φ
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software suite assuming 3-fold symmetry (C3) to account for the pseudo-3-fold
symmetry of the A3B3 complex [148]. Initial models of the DF and CE3G3H subcomplexes were derived from early MULTIREFINE experiments where the particles
were sorted into distinct subdirectories using multivariate statistical analysis (MSA). This
was done assuming no symmetry (C1). Iterative refinement of the final three
reconstructions was performed in subsequent MULTIREFINE experiments assuming C1
symmetry for each. The final A3B3DF, DF and CE3G3H reconstructions used 21,682,
14,873 and 20,128 particles respectively. The resolution of the final reconstructions was
estimated based on a Fourier shell correlation (FSC) criterion of 0.5 using the EOTEST
command within EMAN, which measured the degree of correlation when the data was
split into two halves.
3.2.5 X-RAY FITTING
X-ray coordinates for the T. thermophilus A3B3DF sub-assembly (PDB 3A5D),
subunit F (PDB 2D00), and yeast subunits C (PDB 1U7L) and H (PDB 1HO8) were fit
into the EM density maps using the programs COOT [345], CHIMERA [346], EMFIT
[229] and COLORES [347,348]. X-ray coordinates of the peripheral stalks from T.
thermophilus (PDB 3K5B) were placed into the locations they likely occupy in the V1ATPase to put the reconstruction into context. The program EMFIT [229] was utilized to
assign quantitative values proportional to the relative precision of the X-ray coordinate
fittings. Outputs included an average value of density at all atomic positions between
-100 and +100 (sumf) and a percentage of atoms in negative density (outside of
density). All visualization was done with the programs VMD [349] and Chimera [346].
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3.3

RESULTS

3.3.1 PURIFICATION OF THE YEAST V1-ATPase
Efficient isolation of the highly purified yeast V1-ATPase resulted from the
attachment of a FLAG epitope to the carboxy-terminus of the A subunits. Subsequent
purification using a FLAG antibody conjugated to an agarose resin and size exclusion
chromatography resulted in a highly purified yeast V1-ATPase domain (Figure 3.3).
Detergent was not used in the purification protocol in order to avoid co-purification of the
Vo-domain with the desired V1 component. The fully purified V1-ATPase was found in a
series of sub-complexes, giving rise to the discovery of the CE3G3H sub-assembly.
Mechanical dissociation of the individual sub-complexes from the complete V1-domain
may have occurred during sample purification through the size-exclusion column or may
have resulted from the freeze/thaw cycles during storage of the sample prior to data
collection. The identity and the molecular mass of each of the subunits A, B, C, D, E, F,
G and H were experimentally determined to be 67.7, 57.6, 44.2, 29.2, 26.5, 13.4, 12.7
and 54.4 kDa, respectively using MALDI-TOF mass spectrometry.

Figure 3.3 V1-ATPase sample homogeneity. The purified yeast V1-ATPase sample
visualized by 10% SDS-PAGE.
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3.3.2 THREE-DIMENSIONAL RECONSTRUCTIONS OF THE YEAST V1-ATPase
In examining the cryo-EM micrographs and the resulting class averages, it was
determined that the particles existed in a number of different shapes that were
inconsistent with one another. Visual identification and separation of the different
particles was too difficult to accomplish manually due to the poor contrast of the cryoEM micrographs. However, the MULTIREFINE command within EMAN [148] was able
to split the data set into separate datasets according to particle shape (Figure 3.4). This
separation resulted in three independent reconstructions of the A3B3DF, DF and
CE3G3H sub-complexes that were refined to 14, 18 and 16 Å resolution respectively.
Interestingly, the DF central stalk was captured in two separate reconstructions and in
two different conformations. Collectively the three reconstructions presented here are in
agreement with the most current stoichiometry of the V1-ATPase [336] and constitute
the entire V1-domain.

Figure 3.4 Reference-free class averages of the V1-ATPase A3B3DF, DF and CE3G3H
sub-complexes from the cryo-EM data set.
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3.3.3 THE A3B3DF RECONSTRUCTION
The A3B3DF reconstruction was refined to 14 Å resolution and reveals a unique
central stalk interaction that has previously only been seen in prokaryotic models
(Figure 3.5). At the current resolution, the six individual subunits can be discerned each
having an approximate width of 35 Å. The identity of the A and B subunit locations was
revealed by an automated rigid body fitting of available X-ray coordinates of the A3B3DF
sub-assembly (PDB 3A5D) (Figure 3.6A). The three A subunits appear to have regions
of their density protruding away from the center of the A3B3 complex forming knob-like
densities that are thought to be composed of an amino acid insertion near the aminotermini [350]. Additionally, the three B subunits appear consistent in their shape and
relative size, collectively forming a triangular cap at the point furthest away from the
membrane.

Figure 3.5 The 14Å resolution cryo-EM reconstruction of the catalytic A3B3DF complex.
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The central stalk density has an approximate width of 30 Å and projects 70 Å
from the base of the A3B3 catalytic complex. At its insertion point into the A3B3 complex,
the central stalk interacts with a single catalytic A subunit, consistent with the wellestablished mechanism that describes the coupling of proton-translocation and central
stalk rotation to ATP synthesis in the F-ATP synthase [11]. The spatial occupancy of
this density was validated with the X-ray coordinates for subunit D (PDB 3A5D) in which
the slender α-helical domain of subunit D was fit asymmetrically nearest one of the
catalytic AB interfaces (Figure 3.6). The central stalk also contains an additional density
at its distal end corresponding to an extended conformation of subunit F. When fit with
available X-ray coordinates (PDB 2D00) from T. thermophilus it was confirmed that
subunit F extends contralaterally to interact with a single A subunit thus bridging the
distal end of the central stalk to the base of the A3B3 complex (Figure 3.7). This DFA
rotor-stator interaction is also the likely cause of the central stalk bending to a 45° angle
(Figure 3.6B).

Figure 3.6 (A) X-ray coordinates of the T. thermophilus A3B3DF sub-assembly (PDB
3A5D) fit into the EM density to characterize the A (orange) and B (yellow) trimers as
well as the central stalk (cyan). (B) The orientation of the central stalk in the A3B3DF
reconstruction compared to that of the X-ray coordinates (PDB 3A5D).
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Figure 3.7 The tethering interaction between the extended conformation of subunit F
and the catalytic A3B3 complex of the free V1-ATPase. (A) A close up view of the central
stalk interactions in which subunit F (magenta) is in the retracted conformation (PDB
3A5D). (C) The extended conformation of subunit F (magenta) from T. thermophilus
(PDB 2D00) was fit into the central stalk density to occupy the narrow bridging
interaction that tethers the central stalk to a contralateral A subunit.
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3.3.4 THE DF RECONSTRUCTION
An 18 Å reconstruction of the isolated DF rotary subunits resulted from a particle
alignment centered on the central stalk and not the catalytic subunits as seen in the
A3B3DF reconstruction. As a result, most of the A and B trimer densities were averaged
away due to their misalignment in relation to the now anchored central stalk. Four
globular densities are seen above noise level surrounding the central stalk nearest its
likely insertion point into the A3B3 complex (Figure 3.8A). The centers of three of these
satellite densities are spaced roughly 70 Å apart, corresponding to the relative distance
between the centers of the A or B subunits in the A3B3DF reconstruction. These
densities are approximately 25 Å wide along the short axis of the V1-ATPase and are
representative of the A or B subunits that were mostly disordered.

Figure 3.8 The isolated DF central stalk of the yeast V1-ATPase. (A) The DF
reconstruction is highlighted by a boot-like structure with additional peripheral densities.
(B) Subunits D (cyan) and F (magenta) (PDB 3A5D) fit into the DF reconstruction to
characterize the respective subunit domains. The retracted conformation of F was fit to
compliment the boundaries of the EM density.
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The DF reconstruction features a strong tubular-shaped density that spans
approximately 80 Å about the long axis of the V1-ATPase and is representative of
subunit D as indicated by the fitting of T. thermophilus coordinates (PDB 3A5D) (Figure
3.8). Near its projected insertion point into the A3B3 complex this density has an
approximate width of 30 Å, corresponding to the girth of the central stalk in the A3B3DF
reconstruction. At the distal end, the central stalk contains a protuberance roughly
25 Å long and perpendicular to the orientation of subunit D. This feature adds to the
asymmetry of the complex, giving it a “foot-like” appearance that is occupied by the
retracted conformation of subunit F. The extended conformation was unable to fit into
the DF reconstruction due to a lack of density available for the carboxy-terminus to
extend from the amino-terminus. These results further indicate that subunit F is in the
retracted conformation in the isolated DF reconstruction.
3.3.5 THE CE3G3H RECONSTRUCTION
The 16 Å reconstruction of the CE3G3H sub-complex contains several unique
structural features that support its function and location in the intact V-ATPase (Figure
3.9A). The X-ray coordinates of the yeast V-ATPase subunits C (PDB 1U7L) and H
(PDB 1H08) were fit into the density map to outline the subunit boundaries within the
reconstruction (Figure 3.9B). The EMFIT [229] and COLORES [347,348] programs were
used to fit the X-ray coordinates of subunit C into the CE3G3H density based on model
correlation. The ability of subunit C to bind with two peripheral stalks was also used as a
determining factor in accurately docking the respective X-ray coordinates [298].
Alternative computational and manual fittings of subunit C resulted in a lack of
reasonable density to accommodate the docking of subunit H. The X-ray structure of
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subunit H was fit in the remaining density based on recent biochemical findings in
Neurospora crassa indicating that the amino-terminus of subunit H accommodates the
binding of one of the three peripheral stalks [351]. EMFIT was used to assign
quantitative values to the relative accuracy of these X-ray coordinate fitting, yielding
sumf values of 52 and 60 respectively [229]. These values correspond to a high
average value of density at all of the atomic positions (sumf) as a result of a well placed
fit. Additionally, the percentage of atoms in negative density was 0.05 and 0.03
respectively.
The architecture of the reconstruction can be described as “saddle-shaped”, with
a flat central portion and a pronounced ridge. This saddle-like ridge feature contributes
to the asymmetry of the model and is likely occupied by the amino terminus of subunit H
(Figure 3.9B). Additionally, the carboxy-terminus (residues 371-421) of subunit H was fit
near residues 146-161 and 272-287 of the α-helical “neck” domain in subunit C. This
CH interface has a relative contact area of approximately 4,500 Å2, as determined and
confirmed by the CCP4 programs AREAIMOL and SURFACE [352] and the
INTERSURF command within the Chimera software suite [346]. Additionally, the
CE3G3H complex also contains three distinct vertices, with bulging densities below the
equator of the complex protruding some 15 Å in the direction of the membrane. Two of
these formations are occupied by the “head” (residues 166-263) and a “foot” (residues
1-48 and 324-373) [353] domains of subunit C, while the third is populated by the
amino-termini of subunit H which also serves as the attachment point for one of the
peripheral stalks.
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Figure 3.9 The yeast V1-ATPase CE3G3H Reconstruction. (A) Top and side views of the
CE3G3H peripheral stalk complex characterized by the three elongated peripheral
stalks. From the top of the complex viewing in the direction of the membrane, the
heterodimeric peripheral stalk densities (PS) are outlined in green and lime green to
highlight the likely subunit boundaries of subunits E and G. The density was colored on
the basis of X-ray fitting results of the E/G complex from T. thermophilus (PDB 3K5B)
with a color probing radius of 7Å. (B) Top and side views of the subunit C (blue) and H
(red) interaction highlighted by a precise inter-subunit overlap. Viewing in the direction
of the membrane, the carboxy-terminus (CT) of subunit H (PDB 1H08) fits over the neck
domain of subunit C (PDB 1U7L) characterizing a contact interface area of
approximately 4,500 Å2.
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Located in the flat central portion of the reconstruction is a shallow cavity that
indents approximately 10 Å from the outer border of the complex and is roughly 20 Å
wide. Surrounding this cavity are three strong slender elongated densities seen
protruding in the direction of the catalytic complex that clearly represent the peripheral
stalks. These extensions are approximately 40 Å long but are likely much longer.
However due to their flexibility and subsequent disorder, portions near their distal ends
were averaged away. Despite the lack of rigidity, the remainder of these elongated
densities could be interpreted by the fitting of the X-ray coordinates of the EG
heterodimer (PDB 3K5B) (Figure 3.10) [354]. It is worth noting that the presence of
these three densities is not the result of particle misalignment due to the pronounced
asymmetries within the reconstruction such as the large saddle-like ridge and the
central cavity. Misalignment of particles would not result in such strong asymmetric
features.

Figure 3.10 Top and side views of the CE3G3H sub-assembly with 50% transparent EG
heterodimer densities (PDB 3K5B green and lime green) incorporated into the density
map to further outline the orientation of the three peripheral stalks relative to subunits C
(PDB 1U7L blue) and H (PDB 1H08 red).
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3.4

DISCUSSION
The V-ATPase is a dynamic rotary enzyme that hydrolyzes ATP through a series

of differing conformational states, making it difficult to refine a three-dimensional
reconstruction of the enzyme to a reasonable resolution. Additionally the fragility of the
intact V-ATPase and the difficulties associated with capturing complete V-ATPase
particles in a micrograph setting, contribute to the problem of acquiring a high resolution
reconstruction. However, in this study the yeast V1-ATPase was visualized to 14 Å
resolution, illustrating a novel method for the regulation of catalysis upon detachment
from the membrane.
In all V-ATPases the catalytic activity arises from conformational changes
resulting from ATP-binding and hydrolysis on the A subunits near the AB interface
[55,56,58] .These changes drive the rotation of the heterodimeric DF central stalk which
ultimately results in the translocation of protons across the membrane through the
a(cc')4-5c''d proteolipid ring [59,329,355]. The dynamic nature of these subunits allows
them to assume random orientations, resulting in their density likely being averaged
away when computationally analyzed. The only situation in which the DF central stalk
and the A3B3 catalytic complex could be captured in a single predominant orientation is
when the two entities are held motionless by some coherent interaction as seen in our
A3B3DF reconstruction. The importance of such an interaction lies in the maintenance of
cell viability. During brief periods of glucose deprivation, the V-ATPase is regulated by
the V1-domain disassembly from the membrane-bound VO-domain [356]. However
without some form of regulation, the released V1-ATPase can potentially hydrolyze ATP
uncontrollably. Kane and Smardon (2003) postulate that potential hydrolysis of ATP by
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the free V1-ATPase is terminated by subunit H bridging the rotor and stator stalks
together [357]. A similar situation has also been explored with the F1-ATPase and an
additional portion of the F(o)b subunit [358]. However in the A3B3DF reconstruction
presented here, the abnormal tilting of the central rotor stalk to a 45° angle highlights
the extended conformation of subunit F which bridges the rotor and stator entities
together. Additionally, subunit F is also seen in its retracted conformation, further
supporting the notion that subunit F can adopt two variable conformations depending on
ATP availability [308]. The involvement of subunit F in the regulation of the free V1ATPase was first proposed by Makyio et al, 2005 and later supported by
crystallographic data of the A3B3DF sub-assembly from T. thermophilus [61]. This
interaction has not been documented in a eukaryotic V-ATPase until now. By
obstructing the rotation of the central stalk, the V1-ATPase A3B3 complex can stop
cycling between the three nucleotide-binding states thus preventing the unwanted
hydrolysis of ATP. A similar event has also been demonstrated in the F-ATP synthase
in which the extended conformation of the epsilon subunit restricts the rotational kinetics
of the gamma subunit, resulting in the inhibition of ATP hydrolysis [359].
Additionally, I present the first reconstruction of the complete peripheral stalk
architecture of the yeast V-ATPase (subunits CE3G3H). In terms of subunit arrangement
at the V1VO-interface, recent EM reconstructions of the complete yeast V-ATPase have
proposed that subunit H is in close proximity to subunit C; however the two entities do
not actually contact each other [333,340]. On the contrary, it is now clear in the free V1ATPase that the carboxy-terminus of subunit H interacts with the narrow neck domain of
subunit C (Figure 3.11). This arrangement of subunits C and H appears to be extremely
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stable where the interface between the two is approximately 4,500 Å2. Collectively, the
aforementioned variances observed in the subunit orientations at the V1VO-interface are
supported by mutagenesis studies that suggest that the carboxy-terminus of subunit H
is able to assume varying conformations depending on its involvement in either the free
V1- or the complete V-ATPase [341,360].

Figure 3.11 Differences in the orientations of subunits C and H in the complete VATPase and in the free V1-ATPase. (A) In a recent EM reconstruction of the complete
yeast V-ATPase (green density), subunits C (PDB 1U7L-green) and H (PDB 1H08yellow) are seen in close proximity to one another but are proposed to not interact.
Three peripheral stalk densities (red) are seen stabilizing the A3B3 (blue and cyan)
catalytic complex two of which are bound to subunits C and H as indicated by SAXS
[333]. Adapted from Diepholz et al, 2008 [333]. (B) In the free V1-ATPase three
peripheral stalks (PDB 3K5B green and lime green) are seen bound to the CH (PDB
1U7L-blue and PDB 1H08-red) platform.
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The three peripheral stalks seen here are much like those considered in the VATPase reconstructions from the plant Kalanchoe daigremontiana [361], bovine [329],
yeast [333,338,339] and the insect Manduca sexta [340], however in our CE3G3H
reconstruction these densities are more clearly defined. Two of the peripheral stalks
protrude from subunit C, one from the “head” (residues 166-263) and “foot” domains
(residues 1-48 and 324-373), while the third is seen projecting from the amino-terminus
of subunit H. This architecture corroborates published findings [298,336,351,353].
Structurally these elongated peripheral densities extend away from the membrane and
likely interact with the non-catalytic A/B interfaces [137,311,337] to prevent V1 rotation
during catalysis (Figure 3.12). Further evidence of their stator function lies in the
presence of large bulges protruding from the CH base in the direction of the membrane.
The arrangement of these unique densities is such that they are likely involved in
binding with the membrane-bound a subunit at the V1VO-interface [298,341]. As a result,
the EG stalks are indirectly attached to the membrane-bound stationary subunit a
through their interactions with the CH base.
The physiological reasoning for the V-ATPase requiring multiple peripheral stalks
lies in the arrangement of the various stator and rotor components. Based on recent Xray [61] data, the A3B3DF complex spans an approximate distance of 170 Å down the
long axis of the V1-ATPase. This corresponds to the distance from the top of the A3B3
catalytic headpiece to the bottom of the CH base. By comparison, the F-ATP synthase
α3β3γ sub-assembly spans an approximate distance of 130 Å along the equivalent
components [362]. As a result of the increased distance between the A3B3 complex and
the CH peripheral stalk base, the peripheral stalks in the V-ATPase must span a longer
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distance compared to the F-ATP synthase therefore reducing their stability [137]. By
utilizing three peripheral stalks, as opposed to one like in the mitochondrial F-ATP
synthase [363], the V-ATPase is able to accommodate the larger distance and
subsequently stabilize the A3B3 complex against the forces induced by the rotor.

Figure 3.12 A top view of the CE3G3H complex fit with a 50% transparent representation
of the A3B3DF sub-assembly (PDB 3A5D). X-ray coordinates of the EG heterodimer
from T. thermophilus (PDB 3K5B) were fit into the density map to discern the extent of
the three peripheral stalk boundaries. Based on their orientation, the peripheral stalks
(green and lime green) are seen interacting with the non-catalytic interfaces between
the A (orange) and B (yellow) subunits [137,311,337] . This arrangement allows for the
nucleotide-binding interfaces (NBI) to be openly accessible for binding with ATP and
ADP while also facilitating enough space for rotation of the central stalk (subunit D,
cyan).
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Interestingly, the formation of the separate and distinct A3B3DF and CE3G3H subassemblies presented here sheds light on a potential assembly mechanism for the
complete cytoplasmic domain. Based on the relative arrangement of the V1
components, it is likely that the catalytic complex and central stalk collectively dissociate
from the CH peripheral stalk base containing the three peripheral stalks (Figure 3.13).
This nascent schematic is further supported by recent high-resolution structural data
revealing an A3B3DF complex free of subunits C, H, E and G [61]. While the exact
mechanism for this is unclear, subunit C may play the key role as it is the only subunit
that does not co-purify with either the V1 or VO domain after complex disassembly [364].
Additionally, SAXS has revealed that subunit C can adopt two very dynamic
conformations depending on its involvement in the holoenzyme [333]. Such a
conformational change may be stimulated by the phosphorylation of subunit C [364,365]
which is believed to weaken the surface interactions between an EG-C complex
formation [333]. However, the dissociation of subunit C from the EG stator does not
appear to be the method by which the V1-ATPase regulates its assembly as three
copies of the EG complex remain bound with subunits C and H when the CE3G3H
complex is dissociated from the remaining V1- components.
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Figure 3.13 (left) Side view of the CE3G3H reconstruction fit with the subunits C (PDB
1U7L-blue), H (PDB 1H08-red) and three copies of the EG heterodimer from T.
thermophilus (PDB 3K5B-green and lime green). (right) The rigid body fit of the A3B3DF
complex from T. thermophilus (PDB 3A5D-50% transparency), highlights the precision
by which the A3B3DF and CE3G3H sub-complexes fit together. In this arrangement, the
A (orange) and B (yellow) trimers are cradled by the three peripheral stalks while the DF
central stalk (cyan and magenta) is in line with the shallow cavity that surrounds the CH interface.
It is clear that the CH peripheral stalk base is unique to the dissociated V1ATPase and represents a dynamic sub-assembly that may be a primary constituent in
the formation of the complete cytoplasmic domain. It is tempting to hypothesize over the
mechanism by which the V1-ATPase is assembled, however further analysis is required
to identify the physiological stimuli for such an event.
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CHAPTER 4
CHAPERONE-MEDIATED REGULATION OF STEROID HORMONE
RECEPTOR ACTIVITY
4.1

INTRODUCTION
Steroid hormones are a unique group of cholesterol derivatives that are classified

into five separate classes based on their respective physiological effects in the body.
These include the glucocorticoid and mineralocorticoid steroids such as cortisol and
aldosterone, which function independently to decrease inflammation and to regulate salt
and water balance, respectively. Additional steroids include the androgen, estrogen and
progestin families which each play distinct roles in vertebrate reproductive development
[1]. The biological action of androgenic steroid hormones like testosterone and
dihydrotestosterone, is mediated by respective steroid hormone receptors that function
as nuclear transcription factors [366]. The transcriptional effects of androgenic signaling
is responsible for thousands of gene products which collectively play major roles in a
number of physiological processes including cellular proliferation, lipid metabolism and
sex differentiation [366].
Of particular interest, the activation of androgenic steroid hormone receptors
plays an important role in prostate tissues, where the unregulated activity of these
receptors can influence the development of cancer. In a healthy prostate, the
androgen-bound receptor functions through a reciprocal paracrine interaction between
the epithelial and stromal cells which activates a transcriptional cascade that ultimately
stimulates the proliferation of epithelial cells [367]. Under physiological conditions,
ligand-bound androgen receptor prevents the overgrowth of the epithelial compartment
by suppressing cell proliferation and by triggering cellular differentiation
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[367,368,369,370]. However during prostate carcinogenesis, the regulatory function
played by the androgen receptor is often converted from a growth suppressor to an
oncogene which in turn stimulates prostate cancer cell survival and proliferation
[367,371,372].
Within the cytoplasmic milieu, androgenic steroid hormone receptor activity is
tightly regulated by a series of chaperones that stabilize the receptor and maintain its
ability to bind hormone [373,374,375,376]. These primarily include the Heat shock
family of proteins Hsp40, 70 and 90, of which Hsp90 plays the most pivotal role in the
later stages of hormone receptor maturation [377,378]. Hsp90 is the most abundant
molecular chaperone in the cytosol comprising roughly 1-2% of the cytosolic protein
fraction [379]. Hsp90 binds with client proteins through short hydrophobic peptide
sequences and facilitates protein folding through the shuffling between multiple ATPdependent conformations [380,381]. This activity is dependent on the dimeric nature of
Hsp90, which is mediated by a high-affinity dimerization domain in the carboxy-terminal
end of the protein [382,383]. Characteristically Hsp90 is unique in its function in that it is
not solely responsible for the maturation of transcription factors like the steroid hormone
receptors, but instead requires a specific set of substrate proteins it uses as cochaperones [39,380,384,385,386] (Table 4.1). Collectively Hsp90 and its respective
binding partners form dynamic multimeric assemblies in which the co-chaperones are
replaced interchangeably at different stages of the client protein cycle (Figure 4.1).
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Table 4.1 Co-chaperone proteins that function with Hsp90 during client protein folding.
Adapted from Zuehlke and Johnson, 2009 [387].
Co-Chaperone

Effect on Hsp90

Hsp90

(Vertebrates)

ATPase Activity

Binding Site

HOP

Inhibits (Sti1)

C-terminus

Characteristics

References

TPR domains

[49,377]

binds to Hsp70 and Hsp90
PP5

None

C-terminus

TPR domain

[388]

phosphatase domain
FKBP51, 52

None

C-terminus

TPR domain

[389]

peptidyl-prolyl isomerase
Cyp40

None

C-terminus

TPR domain

[390]

peptidyl-prolyl isomerase
TTC4

C-terminus

TPR domain

[391,392]

activates ATPase activity
of Hsp70
XAP2

C-terminus

TPR domain

[393]

AIPL1
Tpr2

C-terminus

TPR domain

[394]

C-terminus

TPR domain and J domain

[395]

GCUNC-45

N-terminus

TPR domain

[396]
[397,398,399]

p23

N-terminus

Stabilizes closed conformation

N-terminus

Binds kinase clients

[400,401]

N-terminus

TPR domain and domain

[402,403]

P50/cdc37

Inhibits

Sgt1

with homology to p23
aha1

Stimulates

Middle domain

Potent activator of Hsp90

[404]

ATPase activity
[374,375,405]
Hdj2

None

None

Hsp40 molecular chaperone,
stimulates ATPase activity of
Hsp70

HIP

None

TPR domain
inhibits ATPase activity of
Hsp70

[406]

Chip

None

TPR domain, ubiquitin ligase,

[407]

binds to Hsp70
Hsp110

None

Nucleotide exchange factor

[408,409]

for Hsp70
SGTα

TPR protein
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[410]

Figure 4.1 A cartoon diagram outlining the chaperone-assisted regulatory cycle of
steroid hormone receptors. The involvement of the Hsp40, 70, 90, HIP, HOP, FKBP52
and p23 proteins in early, intermediate and mature complexes as the steroid hormone
receptor is primed for binding with steroid hormone (SH) and the hormone response
elements (HRE) of the nucleus. This figure was rendered based on the findings of
previous studies [411,412,413].
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In the Hsp90-mediated client protein cycle, the steroid receptor initially
associates with Hsp40 and Hsp70, before being passed on to Hsp90 through
intermediate binding interactions with HOP [411]. Once the receptor is bound to the
Hsp90 dimer, ATP-binding triggers the dissociation of HOP, leading to the subsequent
binding of the Hsp90-receptor complex to other co-chaperones such as p23 and the 52
kDa immunophilin FK506-binding protein (FKBP52) [411]. Once in this mature complex,
the receptor is primed for binding with its respective hormone ligand which in turn
triggers a conformational change exposing the receptor’s zinc-fingered DNA binding
motifs to bind to the nuclear chromatin [414,415].
As part of the mature chaperone complex, the small, acidic co-chaperone p23
binds directly to Hsp90 in a nucleotide-dependent fashion [398]. It is the smallest
component in the Hsp90 machinery (Mr 18,000 - 25,000) and was first discovered in
complex with Hsp90 and the progesterone receptor [416,417]. The complete cellular
function of p23 has not been fully elucidated, however in the context of steroid hormone
receptor regulation, the binding of p23 to Hsp90 is believed to stabilize the ATP-bound
state of Hsp90 by obstructing the nucleotide-binding domains [399,418]. A recent crystal
structure of an Hsp902-p232 complex revealed this interaction in which p23 is seen
bound to the amino-termini of Hsp90 through hydrophobic interactions [399]. As a
result, p23 stabilizes the conformational changes induced by ATP binding which in turn
triggers the subsequent binding of immunophilin proteins and the activation of the
steroid hormone receptor to its high-affinity ligand-binding state [45,49,419,420].
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FKBP52 is a large peptidyl-prolyl cis-trans isomerase (PPIase) immunophilin
protein that carries the ability to bind to immunosuppressive drugs. Structurally, FKBP52
consists of carboxy- and amino-termini that each have distinct roles in steroid hormone
receptor regulation. A tetratricopeptide repeat domain (TPR) at the carboxy-terminus
characterizes the binding surface for the well-defined -EEVD sequence motif at the
carboxy-terminus of Hsp90 [421,422,423,424]. However, FKBP52 may also interact with
the middle-domain (MD) of Hsp90 at a hydrophobic patch surrounding Trp300
[425,426,427] as seen with the Cdk4 kinase [428]. The amino-terminus of FKBP52 is
highlighted by the FK-1 and FK-2 domains. Of particular interest, the FK-1 domain is
believed to be largely responsible for FKBP52-mediated potentiation of receptor
efficiency by providing the binding surface for the receptor [389,421,429]. Mutagenesis
studies have indicated this to be true for point mutations in and around the FK-1
domain. These findings reveal that FKBP52-mediated potentiation of receptor activity is
significantly abrogated in glucocorticoid (GR), androgen (AR) and progesterone (PR)
receptor models [389,421,429,430,431]. The physiological significance of FKBP52 has
also been elucidated in knock out (KO) studies where male mice lacking the Fkbp4
gene that encodes for FKBP52 display several developmental defects such as having
ambiguous external genitalia and dysgenic prostate and seminal vesicles [430,432].
In addition to p23 and FKBP52, HOP and the Small Glutamine-rich
Tetratricopeptide protein (SGTα) each play individual roles in steroid hormone receptor
regulation by acting as intermediaries between Hsp70 and Hsp90. HOP recruits Hsp90
to interact with preexisting receptor-Hsp70 complexes, thus facilitating the wellarticulated progression towards a fully mature receptor complex in which the receptor is
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primed for ligand-binding [373,376,377,420,433]. SGTα is believed to interact with
Hsp70 and 90 in a similar fashion [410]; however its role in the regulation of receptor
activity remains to be elucidated. Like FKBP52, HOP and SGTα are both TPR domaincontaining proteins and characteristically bind to Hsp90 in a very similar fashion [434].
FKBP52 and HOP are believed to both carry the ability to bind to Hsp90 at multiple
sites, doing so in a competitive fashion while interacting at separate stages in the
receptor cycle [377,411,419,435,436]. In the case of SGTα, it remains unclear whether
there is competition for Hsp90 binding with the other TPR domain-containing proteins.
To date, the structural architecture of the intermolecular interactions between
Hsp90 and its respected co-chaperone binding associates is still poorly understood,
despite recent crystallographic data of the Hsp902-p232 complex [399]. In particular, our
understanding of the interactions between Hsp90 with the various TPR domaincontaining proteins remains unclear due to the lack of available high-resolution
structures. As a result, little is known of how the steroid hormone receptor is stabilized
in the presence and absence of available hormone or how these interactions could be
exploited for in vitro control of the aforementioned regulatory pathway. Collectively
these factors provide the basis for the work presented here.
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4.2

MATERIALS AND METHODS

4.2.1 EXPRESSION OF THE p23, FKBP52, HOP, SGTα AND Hsp90α PROTEINS
The human p23 co-chaperone was expressed as an untagged construct in the
pET23b+ vector. The human FKBP52 and HOP proteins were expressed as aminoterminal 6x-histidine-tagged constructs in the pET28b+ vector. Additionally the human
SGTα and Hsp90α proteins were expressed in the pET28b+ vector system as a
carboxy-terminal 6x-histidine-tagged constructs. All recombinant constructs were
transformed into the E. coli BL21* DE3 competent cell system (Invitrogen, USA) and
were isolated on LB-agar plates containing the appropriate antibiotic. All transformants
were grown at 37°C in 1L cultures of 2xTY media until reaching an optical density of
0.8-1.0 (OD600). Protein expression was induced with Isopropyl β-D-1-thiogalactoside
(IPTG) to a final concentration of 1mM. After a 5 hour incubation at 30°C, the cells were
harvested by centrifugation (6,000xg, 60 minutes, 4°C) and resuspended in a 50mM
Hepes-KOH, 10mM EDTA, 1mM PMSF lysis buffer (pH 7.5). Hen egg white lysozyme
(Sigma, USA) was added to the respective resuspensions at a 2.5mg/ml final
concentration prior to an initial freezing at -20°C.
4.2.2 CELL DISRUPTION
The E. coli expression cells containing the respective p23, FKBP52, HOP, SGTα
and Hsp90 proteins were mechanically lysed through multiple freeze/thaw cycles.
Cell/lysate emulsions were treated with MgCl2 to a final solution concentration of 25mM
in conjunction with the addition of trace amounts of bovine pancreatic DNase I (Sigma,
USA). Each mixture was rocked on ice for 60 minutes to facilitate DNA degradation prior
to harvesting the cell lysate by centrifugation (20,000xg, 60 minutes, 4°C).
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4.2.3 CHROMATOGRAPHIC PURIFICATION OF THE p23 CO-CHAPERONE
The human p23 protein was initially purified over a quadruple-stack of 5ml DEAE
FF anion-exchange columns (GE Life Sciences, Sweden) that were equilibrated with
50mM Hepes-KOH, 10mM MgCl2, 1mM DTT, 1mM PMSF, 0.02% NaN3 (pH 6.0). Prior
to loading, the p23-containing lysate was diluted in the equilibration buffer (pH 6.0) to
bring down the pH of the sample. The target protein was eluted over a 100ml 0-600mM
NaCl gradient with a 5ml/min buffer flow rate. The target fractions were then passed
through a HiLoad Q-Sepharose 26/10 anion-exchange column (GE Life Sciences,
Sweden) that was equilibrated with 50mM Hepes-KOH, 10mM MgCl2, 1mM DTT, 1mM
PMSF, 0.02% NaN3 (pH 7.5). p23 was separated over a 400ml, 0-600mM NaCl gradient
that was executed under a flow rate of 4ml/min. The p23 sample was further purified by
treatment with a HiPrep Sephacryl S-200 16/10 size-exclusion column (GE Life
Sciences, Sweden) that was equilibrated with 50mM Hepes-KOH, 150mM NaCl, 50mM
KCl, 10mM MgCl2, 1mM DTT, 1mM PMSF, 0.02% NaN3 (pH 7.5), with elution occurring
at a 0.5ml/min flow rate. The target protein elutions were pooled together and were
dialyzed extensively against 50mM Hepes-KOH, 50mM KCl, 10mM MgCl2, 1mM DTT
(pH 7.4) prior to sample concentration and analysis. The final samples were stored at 80°C.
4.2.4 CHROMATOGRAPHIC PURIFICATION OF FKBP52, HOP AND SGTα
The 6x-histidine-tagged FKBP52, HOP and SGTα proteins were individually
purified over a 5ml Ni-NTA HisTrap FF Crude column (GE Life Sciences, Sweden).
Prior to column loading, the respective lysates were treated with imidazole to a final
concentration of 20mM. The column was equilibrated and washed with 50mM Hepes-
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KOH, 100mM NaCl, 10mM MgCl2, 20mM Imidazole, 1mM PMSF, 0.02% NaN3 (pH 7.5)
and the respective proteins were eluted over 20-500mM Imidazole step gradients with a
5ml/min flow rate. In separate experiments the FKBP52, HOP and SGTα target fractions
were further purified on a HiLoad Q-Sepharose 26/10 anion-exchange column as
previously described. Additionally the three TPR domain-containing proteins were
subsequently passed through a HiPrep Sephacryl S-200 16/10 column as previously
described. All proteins were dialyzed and stored in the aforementioned fashion.
4.2.5 CHROMATOGRAPHIC PURIFICATION OF THE Hsp90 CHAPERONE
The 6x-histidine-tagged Hsp90 protein was initially purified over the HisTrap FF
Crude and Q-Sepharose anion-exchange columns as previously described.
Subsequently the target elutions were pooled and concentrated prior to being loaded
onto a Phenyl Sepharose 16/10 hydrophobic interactions column (GE Life Sciences,
Sweden) that was equilibrated with 50mM Hepes-KOH, 10mM MgCl2, 1.5M Ammonium
Sulfate, 1mM PMSF, 1mM DTT, 0.02% NaN3 (pH 7.4). Hsp90 was eluted from the
column with 50mM Hepes-KOH, 1mM PMSF, 1mM DTT, 0.02% NaN3 (pH 7.4) and was
dialyzed and stored accordingly.
4.2.6

MOLECULAR WEIGHT AND PURITY ANALYSIS
The molecular weight of the p23, FKBP52, HOP, SGTα and Hsp90 proteins and

the relative homogeneity of each sample were determined by 10% SDS-PAGE and the
Experion™ Automated Microfluidic Electrophoresis station (BIO-RAD Laboratories,
USA). The Experion automated electrophoresis system utilizes LabChip microfluidic
separation technology and fluorescent sample detection (Caliper Life Sciences) to
perform automated analysis of multiple protein samples [437]. Protein concentrations
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were determined spectrophotometrically via BCA assay against a 2mg/ml bovine serum
albumen standard.
4.2.7 Native-PAGE ANALYSIS
All individual protein samples and protein mixtures were resolved by 7.5%
polyacrylamide in which no detergents, reducing or denaturing agent were used in any
of the resolving, stacking or loading buffers. 5µg of total protein was loaded into each
well with the Hsp90, FKBP52, HOP and p23 proteins being mixed together in their
designated 2:1:2:2 molar ratios in the respective experiments. All protein complex
mixtures were incubated at 30°C for 60 minutes. The samples were not treated with
heat prior to loading and all electrophoresis was done on ice.
4.2.8 Hsp902-FKBP521-p232-HOP2 COMPLEX IMMUNOPRECIPITATION ASSAYS
In each experiment 25µl of Protein A-Sepharose beads (GE) was equilibrated
with 40µg of monoclonal Hsp90 (H90-10) antibody at room temperature for 30 minutes
in a 500µl of 50mM Hepes-KOH, 50mM KCl, 10mM MgCl2 , 1mM DTT solution (pH 7.4).
The beads were washed multiple times and recovered by centrifugation prior to loading
40µg of Hsp90α bait protein. To test the specificity of the Hsp90 antibody 40µg of p23,
FKBP52 and HOP were alternatively added in separate negative control reactions. The
antibody/protein mixtures were incubated for 1 hour on ice with the pellets being
harvested by centrifugation and washed multiple times in the previously described
buffering system. To assess the simultaneous binding of FKBP52 and HOP to Hsp90,
Hsp90-bound antibody/Protein A beads were saturated with five-fold molar excesses of
each of the respective proteins in a step-wise fashion. At each step the protein mixtures
were incubated at 30°C for 60 minutes with gentle shaking occurring every five minutes.
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After the first incubation the beads were washed extensively prior to another five-fold
molar excess addition of the second TPR domain-containing protein. In additional
experiments the p23, FKBP52, and HOP proteins were added to the Hsp90 bait in
equimolar amounts according to the 2:1:2:2 molar binding ratios in the Hsp90-FKBP52p23-HOP complex. The protein mixtures were incubated at 30°C for 60 minutes with
gentle shaking occurring every 5 minutes. The buffering system was augmented with a
5mM ATP, 20mM Na2MoO4 supplement and a 0.01% w/v dose of the non-ionic
detergent dodecyl-maltopyranoside in respective experiments. All unbound proteins
were washed away from the Hsp90 bait with multiple washes and the harvested beads
carrying Hsp90 and the bound complex constituents were resolved by 10% SDS-PAGE.
4.2.9 SGTα/FKBP52 COMPETITION IMMUNOPRECIPITATION ASSAY
In each experiment 10µl of Protein A-Sepharose beads (GE) was equilibrated
with 2.5µg of monoclonal SGTα antibody at room temperature for 30 minutes in a 50mM
Hepes-KOH, 50mM KCl, 10mM MgCl2 ,1mM DTT buffering solution (pH 7.4). The beads
were washed multiple times and recovered by centrifugation prior to loading 20µg of
SGTα bait protein. To test the specificity of the SGTα antibody, 31 and 100µg of
FKBP52 and Hsp90 were alternatively added in separate negative control reactions,
respectively. Additionally, 20, 31, and 100µg of SGTα, FKBP52 and Hsp90 respectively,
were added to 1.5µg of rabbit IgG as negative controls. The antibody/protein mixtures
were incubated for one hour on ice with the pellets being harvested by centrifugation
and washed multiple times in the previously described buffering system. To analyze the
competitive action of SGTα and FKBP52 for the binding of Hsp90, 100µg of Hsp90 was
added to SGTα-bound antibody/Protein A beads to fulfill the 1:2 binding ratio. In three
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separate experiments, FKBP52 was also added to the SGTα-bound antibody/Protein A
bead mixture in 0:2, 1:2 and 2:2 molar ratios with Hsp90. The protein mixtures were
incubated at 30°C for 60 minutes with gentle shaking occurring every five minutes. All
unbound proteins were washed away from the SGTα bait with multiple washes and the
harvested beads carrying SGTα and the bound complex constituents were resolved by
10% SDS-PAGE. In a similar fashion, the SGTα/FKBP52 competition for the binding of
Hsp90 was also resolved by Co-immunoprecipitation using a monoclonal Hsp90
antibody (H90-10). In these experiments the SGTα and FKBP52 proteins were added to
the Hsp90 bait in the appropriate amounts according to the designated molar binding
ratios.
4.2.10 ANALYTICAL SIZE-EXCLUSION CHROMATOGRAPHY
A 200 µl sample of 18µg/µl Hsp902-FKBP521-p232-HOP2 complex was passed
through a Superose6 size-exclusion column (GE Life Science). The complex was
separated from unbound constituent proteins over a 50ml elution period using a 50mM
Hepes-KOH, 50mM KCl, 10mM MgCl2, 1mM PMSF, 1Mm DTT, 0.02% NaN3 buffer. The
chromatography results were visualized by 10% SDS-PAGE.
4.2.11 DYNAMIC LIGHT SCATTERING
The diameter of the solvation layers surrounding each of the constituent proteins
(hydrodynamic diameter) was measured in the Zetasizer Nano series system (Malvern,
USA). 0.02mg/ml samples of each of the individual proteins were measured at 30°C
with measurements occurring every 15 seconds for a total of 50 measurements.
Complex formation as a function of time was analyzed on 0.02mg/ml samples of the
Hsp902-FKBP521-p232-HOP2 complex with each component being present in its
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respective molar binding ratio. Measurements were taken over the course of 90 minutes
in a 50mM Hepes-KOH, 50mM KCl, 10mM MgCl2, 1Mm DTT solution (pH 7.4) with and
without the addition of the 5mM ATP, 20mM Na2MoO4 and detergent supplements. The
step-wise formation of the complex was initially analyzed on a 0.02mg/ml sample of
Hsp90. Each binding protein was sequentially added to the protein mixture in the
appropriate molar ratio. The accuracy and reproducibility of each experiment was
analyzed by standard deviation within a 95% confidence interval using the Graph Pad
Prism software suite.
4.2.12 ELECTRON MICROSCOPY
The p23, FKBP52, HOP and Hsp90 proteins were diluted down from their
respective 7, 9, 8, and 9 mg/ml concentrations to a final complex concentration of 0.02
mg/ml by mixing the constituents together according to their molar ratios in the Hsp902FKBP521-HOP2 and Hsp902-FKBP521-p232-HOP2 complexes. The individual proteins
were incubated together at 30°C for 60 minutes as previously indicated in DLS
experiments. The sample was blotted onto holely-carbon grids and stained with 2%
methyl-amine tungstate.
Images of the Hsp902-FKBP521-HOP2 complex were collected on a JEOL 3200
transmission electron microscope operating at a voltage of 300,000 V (Indiana
University, Dr. David G. Morgan). CCD images were collected at 80,000x magnification.
6432 individually boxed particles were isolated from the 186 micrograph using the
program BOXER within the EMAN software suite [148]. The boxed particles were sorted
into 300 different class averages representative of the variable sizes and orientations of
the particles using the REFINE2D command.
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Images of the Hsp902-FKBP521-p232-HOP2 complex were collected on a Hitachi
transmission electron microscope operating at a voltage of 80,000 V (New Mexico State
University-Dr. Peter Cooke). CCD images were collected at 100,000x magnification.
Individual particles were boxed from the micrograph using the program BOXER within
the EMAN software suite [148].
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4.3

RESULTS

4.3.1 EXPRESSION OF Hsp90 AND THE Hsp90 CO-CHAPERONES
The bacterial BL21* DE3 system was used to express the human Hsp90α protein
to sizeable quantities. It was observed that there was no noticeable difference between
the expression levels of the α and β isoforms (Figure 4.2). Concurrently the FKBP52,
HOP, p23 and SGTα Hsp90-binding proteins were also expressed in the BL21* DE3
system to extremely high yields (Figure 4.2, Table 4.2). In all cases, the addition of
IPTG to a final concentration of 1mM was considered optimal for the induction of target
protein expression as higher concentrations of the inducing agent did not result in
higher expression yields (data not shown). Additionally, an incubation of 5 hours at 30°C
was determined to be ideal for producing large amounts of the respective proteins.

Figure 4.2 Crude lysate samples of the respective proteins resolved by 10% SDSPAGE. Hen egg white lysozyme used in the bacterial lysis process is denoted in the
bottom right.
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Under these conditions, the four Hsp90-binding proteins were expressed at
levels above 80 mg/L each comprising at least 20% of the total protein profile within
their respective bacterial lysates (Table 4.2). Interestingly the HOP recombinant
expressed the most protein where the total expression yield was above 100 mg (Table
4.2). It is worth noting that the high expression level of the Hsp90-binding proteins in
addition to the recombinant incorporation of 6x-histidine tags to the FKBP52, HOP and
SGTα proteins did not result in any detectable amount of protein aggregation nor did it
affect the ability of the respective proteins to bind to Hsp90. Furthermore the inclusion of
a carboxy-terminal 6x-histidine tag to Hsp90 did not affect its ability to hydrolyze ATP.
p23 was expressed as an untagged construct based on the observation that affinity
binding tags interfere with p23’s ability to bind with Hsp90 (unpublished observation).
Table 4.2 The high-yield expression profiles of Hsp90 and the Hsp90-associating
proteins. Each Hsp90-, FKBP52-, HOP-, p23- and SGTα-containing bacterial crude
lysate was analyzed using the Bio-Rad Experion™ microfluidic electrophoresis unit. For
each protein, values included a percentage (%) of target protein occupancy in the
respective crude lysate and a resulting target concentration. (*) Each sample was
diluted 1:5 in a 50mM Hepes-KOH solution to maintain the expression yield of
recombinant targets within the linear range of the Experion instrument (2.5-2000ng/µl).
The total expression yields for the four proteins were derived from the calculated
Experion values in conjunction with the respective dilution factor and the resulting
lysates volumes garnered upon bacterial resuspension (~25ml).
TARGET
PROTEIN
Hsp90
FKBP52
HOP
p23
SGTα

% OF TARGET
IN CRUDE
LYSATE
5.3 +/-0.6
20.4 +/-0.8
26.7 +/-0.1
45.4 +/-0.5
30.9 +/-0.1

CONCENTRATION OF
TARGET IN CRUDE*
(ng/µl)
105.5
647.2
825.4
671.4
650.0
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+/42.6
+/-35.2
+/-104.3
+/-50.0
+/-25.2

EXPRESSION
YIELD (mg/L)
13.4
80.9
103.5
83.9
81.2

4.3.2 PURIFICATION OF Hsp90, FKBP52, HOP, p23, and SGTα
Hsp90 and its respective binding proteins were individually purified using a
number of column chromatographic techniques. Automated electrophoresis was used
to analyze each target protein on the basis of molecular weight as a function of
microfluidic channel migration (Figure 4.3). The percentage of target protein in relation
to the total protein per sample was measured to highlight the relative homogeneity of
each sample (Table 4.3).

Figure 4.3 The homogeneity of steroid hormone receptor chaperones and cochaperones.(left) A Laser excitation fluorescent detection chromatogram revealing the
relative micro-fluidic migration positions of the p23 (blue), SGTα (orange), HOP (green),
FKBP52 (red) and Hsp90 (cyan) proteins depicted as a function of fluorescence versus
time. Note the lack of extraneous fluorescent peaks in each of the respective
chromatograms that would be representative of protein contaminates. (right) 10% SDSPAGE results further illustrating the relative homogeneities of the five protein samples
under investigation. 2µg of total protein was resolved in each of the respective wells.
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Table 4.3 BIO-RAD Experion™ statistical analysis of the purified p23, SGTα, HOP
FKBP52 and Hsp90 protein samples. Automated electrophoresis was able to quantify
the migration times through the microfluidic channels of the Pro260 chips (seconds), as
well as the estimated molecular weights (kDa) and relative degrees of homogeneity (%)
of the respective protein samples.

Protein
p23
SGT
HOP
FKBP52
Hsp90

Molecular
Weight
Mr (kDa)
22.28
36.90
70.19
77.26
88.40

Migration Time
sec
27.02
30.48
35.84
36.88
38.02

Purity
%
96.30
95.10
98.60
99.80
85.80

Automated electrophoresis was also used to analyze the purification of each of
the target proteins in a step-wise fashion illustrating the relative efficiency of the
chromatographic purifications (Figure 4.4). As the result of the three step purification
process, the FKBP52, HOP, p23, and SGTα protein samples each surpassed the level
of 95% homogeneity, with FKBP52 and HOP reaching at least 98% homogeneity (Table
4.4). Interestingly, anion-exchange chromatography was the most effective method of
separation in which a 46.8% pure Hsp90 sample eluted as a 78.5% pure sample.
Furthermore all of the Hsp90-binding proteins eluted from the Q-Sepharose column with
greater than 93% homogeneity (Table 4.4).
In addition to the high level of purity attained for each purified sample, the Hsp90binding proteins were produced and recovered in yields greater than 50mg per liter of
cultured media.
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Figure 4.4 Automated microfluidic electrophoresis analysis of the step-wise purification
of the Hsp90, FKBP52, HOP, p23 and SGTα proteins. (A) A Laser excitation fluorescent
detection chromatogram revealing the relative micro-fluidic migration positions of the
molecular weight standards (values in kDa) depicted as a function of fluorescence
versus time. (B-F) Laser excitation fluorescent detection chromatograms revealing the
relative positions of the Hsp90 (cyan), FKBP52 (red), HOP (green), p23 (blue) and
SGTα (orange) peaks in relation to the microfluidic migration volume of the Pro260
chips. The four individual chromatograms are increasing in contrast of the respective
colors to represent the step-wise purification of the substrate proteins (1. Crude-lightest,
2. DEAE/HisTrap-light, 3. Q-Sepharose-dark, 4. HIC/SEC-darkest). The noise from
contaminating proteins decreases with each purification step and is essentially gone by
the 4th step (darkest spectra), highlighting the final homogeneity of each sample.
85

Table 4.4 Separation efficiency of the Hsp90, FKBP52, HOP, p23 and SGTα protein
samples as determined by microfluidic electrophoresis. The +/- values represent the
deviation from the mean of three separate and independent measurements.

SAMPLE
PROTEIN

1. CRUDE

2. DEAE

HOMOGENEITY

(%PURITY)

2. HISTRAP

3. Q-AEX

+/-1.9

5.3

+/-0.6

46.8

FKBP52

20.4

+/-0.8

87.3 +/-0.9

98.5 +/-0.5

99.8 +/-0.0

HOP

26.7

+/-0.1

74.9 +/-0.4

93.7 +/-1.6

98.6 +/-0.5

p23

45.4

+/-0.5

94.3 +/-0.1

96.3 +/-1.0

SGTα

30.9

+/-0.1

94.4 +/-0.1

95.1 +/-0.2

64.0 +/-2.0
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+/-1.1

4. SEC

Hsp90

58.9 +/-8.2

78.5

4. HIC
85.8 +/-1.5

4.3.3 ISOELECTRIC SEPARATION OF Hsp90 AND Hsp90 CO-CHAPERONES
As a second chromatographic measure, each protein was passed through a QSepharose AEX column using a shallow 0-600mM NaCl gradient to separate the
respective proteins as a function of their molecular charge at a pH of 7.5 (Table 4.5).
The relative elution positions of the five individual proteins within the NaCl gradient
correlated very well with their respective isoelectric point (pI) values and corroborated
previous experimental and theoretical results [416,438] (Figure 4.5). The HOP and
FKBP52 proteins have the most basic pI values (6.40 and 5.35) and eluted the earliest
within the NaCl gradient due to their weak binding to the CH2N+(CH3)3 column matrix.
Conversely, the more acidic SGTα and p23 proteins (4.81 and 4.35) each eluted much
later in the gradient. Based on a linear regression of the correlation between elution
position and pI, future elution positions of proteins with pI values between 4.35 and 6.40
could be accurately interpolated with approximately 93% confidence (Figure 4.5C).
Table 4.5 Q-Sepharose anion-exchange elution positions of the substrate proteins in
relation to their respective pI values. The Hsp90 and p23 homolog proteins from yeast
(Hsc82 and sba1) proteins were also purified using this method to further highlight the
effectiveness of the designated NaCl gradient in separating steroid hormone receptor
chaperons.
Protein
HOP
FKBP52
SGTα
Hsc82
Hsp90
sba1
p23

1° Sequencebased
pI
6.40
5.35
4.81
4.76
4.97
4.46
4.35
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[NaCl] at Elution
mM
180
220
320
330
340
350
390

Figure 4.5 Q-Sepharose anion-exchange elution profiles of the respective
chromatography experiments. (A) The human Hsp90 (cyan) and yeast Hsc82 (violet)
proteins eluted at two separate and distinct points in the NaCl gradient (black). (B) The
HOP (green), FKBP52 (red), SGTα (orange) and p23 (blue) proteins characteristically
eluted at different positions in the 0-600mM NaCl gradient (black) as a result of their
respective molecular charges at a pH 7.5. Colored stars aligned to the right y-axis
represent the NaCl concentration at which each individual protein eluted from the NaCl
gradient. (C) A linear regression correlating the elution positions of the substrate
proteins with their respective pI values. The elution profiles of the Hsc82 and sba1
(pink) proteins were incorporated into the linear regression to further accentuate the
measured correlation.
Of particular interest Hepes-KOH was used as the buffering agent in all of the
AEX separations with the Q-Sepharose column. This differs from the recommended use
of Tris-HCl as the buffering agent as it was found that the use of Hepes-KOH yielded a
higher degree of protein separation likely due to a more selective counter-ion.
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4.3.4 Hsp90, FKBP52, HOP, p23 AND SGTα DIMERIC SPECIES
In the process of purifying the individual proteins for incorporation into the various
chaperone assemblies of the steroid hormone receptor regulatory cycle, it was revealed
that each substrate protein carries the ability to form multimeric species (Table 4.5). The
elution positions of Hsp90, HOP, FKBP52 and p23 in a size-exclusion (SEC)
chromatogram indicated that each respective protein eluted as a dimer species (Figure
4.6). Additionally, p23 also eluted further downstream of its dimeric species as a
monomer. Interestingly, SGTα eluted in a tetrameric conformation while it was
previously thought to be maintained as a dimer in solution [410]. The oligomeric states
of each protein were validated against a linear regression derived from 7 known protein
standards and their well-resolved elution points from the Sephacryl S-200 column
(Figure 4.6B) (Table 4.5).
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Figure 4.6 The existence of substrate dimers and tetramers as observed by sizeexclusion chromatography. (A) During analytical size-exclusion chromatography
experiments, the p23 protein (blue) eluted as two distinct peaks representative of dimer
and monomer species. The FKBP52 (red), HOP (green), SGTα (orange), and Hsp90
(cyan) proteins each eluted as single isolated peaks. Colored stars representative of
each individual protein line the x-axis to highlight the respective elution points relative to
volume. The two p23 peaks are individually represented by a blue (dimer) and a light
blue (monomer) star. (B) A linear regression was performed on the well-established
elution points of 7 protein standards to interpolate the molecular weights of the
substrate proteins from their respective elution positions. The colored triangles
represent the interpolated molecular weight values derived from the linear regression
(R2=0.89) while the colored circles denote molecular weight values derived from primary
sequence information. Each protein is labeled to highlight its assumed multimeric
conformation.
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Table 4.6 The molecular weights and multimeric species of each binding associate.
Theoretical molecular weight values are interpolated from a linear regression of
previous size-exclusion chromatography results from well-known molecular weight
standards.

Protein
Hsp90
HOP
FKBP52
SGTα
p23 A
p23 B

1° Sequencebased
Mr (kDa)
84.67
62.64
51.81
34.07
18.9
18.9

Interpolated
Mr (kDa)
169.00
145.62
117.32
133.83
70.17
23.00
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Multimeric
Species
dimer
dimer
dimer
tetramer
dimer
monomer

4.3.5 STOICHIOMETRIES OF THE Hsp90 INTERACTIONS
A series of Native PAGE experiments were conducted to assess the respective
protein binding ratios of Hsp90 with p23 and the TPR domain-containing proteins. It was
revealed that a significant amount of FKBP52 remained unbound when added to Hsp90
in a 2:2 molar ratio (Figure 4.7). For this reason, FKBP52 was added to Hsp90 in a 1:2
molar ratio in all subsequent experiments. The molar binding ratios HOP and p23 have
with Hsp90 were indecipherable by Native-PAGE due to the indiscernible size
difference between the HOP and Hsp90 dimers and the seemingly weak affinity Hsp90
has for p23. As an alternative, the HOP and p23 proteins were added to Hsp90 in a 2:2
or dimer-dimer molar ratio based on recently published isothermal titration calorimetry
studies and crystallographic data [399,411].

Figure 4.7 The stoichiometry of the Hsp90-FKBP52 interaction as determined by NativePAGE. When FKBP52 was added to Hsp90 in a 1:2 ratio there was a noticeable upward
shift in the position of the Hsp90 band in both the absence and presence of 5mM ATP,
20mM Na2MoO4 (lanes 1-2 respectively). When added in a 2:2 ratio there fails to be an
additional upward shift in the position of Hsp902-FKBP521 band, also illustrated by the
large independent band of unbound FKBP52 (lanes 3-4).
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4.3.6 THE SIMULTANEOUS BINDING OF FKBP52 AND HOP TO Hsp90
A series of immunoprecipitation experiments were performed to investigate the
binding of p23, FKBP52 and HOP to the Hsp90 dimer using a monoclonal Hsp90
antibody in conjunction with Protein A-Sepharose beads. Initially, a series of control
experiments were executed to highlight the direct specificity of the Hsp90 antibody
(Figure 4.8A). Subsequently the simultaneous binding of FKBP52 and HOP to Hsp90
was tested revealing that the two proteins act independently of one another and in a
non-competitive fashion (Figure 4.8B). Hsp90-bound antibody/Protein A beads were
treated with a five-fold molar excess of FKBP52 protein to completely saturate the
designated FKBP52 binding sites on the Hsp90 particles. After thorough washing, the
beads containing FKBP52 bound to Hsp90 were treated with a five-fold molar excess of
HOP to determine if HOP could still bind. Executing the Co-IP experiment in this fashion
ensured that the proteins bound to the final bead pellets were representative of FKBP52
and HOP binding at two different locations on Hsp90 and not a mixture of species in
which the two proteins shared the same binding location (Figure 4.8B, lane 4). A
separate experiment was executed simultaneously where the Hsp90-bound beads were
first treated with a five-fold molar excess of HOP protein and then a five-fold molar
excess of FKBP52 (Figure 4.8B, lane 8). The increased intensity of the final HOP
protein bands compared to the final FKBP52 bands (Figure 4.8B, lanes 4 and 8)
indicate that the binding affinity that Hsp90 has for HOP is likely much greater than that
for FKBP52. It is also worth noting that the simultaneous binding of these TPR domaincontaining proteins was independent of both ATP and p23 as both were absent in each
experiment.
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Figure 4.8 Co-immunoprecipitation experiments reveal the simultaneous binding
interactions of Hsp90 with the two TPR domain-containing proteins FKBP52 and HOP.
(A) Hsp90-antibody specificity. Three negative controls (-) were performed in which the
protein A Sepharose-Hsp90 antibody beads were incubated with 40µg the p23, FKBP52
and HOP proteins respectively. A positive control (+) incorporating 40µg Hsp90 into the
antibody-bead mixture was also executed. Hsp90 was used as the bait protein for the
subsequent experiments. (B) The simultaneous binding of FKBP52 and HOP to Hsp90.
Lanes 1-3 represent excess unbound protein in the initial washout fractions when
Hsp90 (lane 1) was treated with a five-fold molar excess of FKBP52 (lane2) followed by
a five-fold molar excess of HOP (lane 3) in a step-wise fashion. Lanes 5-7 represent a
similar experiment in which HOP was added prior to FKBP52. Lanes 4 and 8 both
represent noticeable amounts of Hsp902-FKBP521-HOP2 complex that were bound to
the final antibody/Protein A-Sepharose bead pellets. Both the control experiments and
the saturation experiments were resolved by 10% SDS-PAGE.
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4.3.7 FKBP52- AND HOP-BINDING IN THE PRESENCE OF NUCLEOTIDE
In order to determine the effect ATP has on the FKBP52 and HOP interactions
with Hsp90, additional experiments were performed in the presence of a 5mM ATP and
20mM Na2MoO4 (Figure 4.9A). ATP was added to trap the Hsp90 dimer in its ATPbound conformation from which we could determine the relative effects conformational
changes have on complex formation. As a result, the binding of FKBP52 to Hsp90
appeared to be unaffected by the addition of ATP in both the Hsp902-FKBP521-p232
and Hsp902-FKBP521-p232-HOP2 complexes (Figure 4.9A, lanes 1-2, 4-5). On the
contrary, the relative degree of HOP binding to Hsp90 appears to be slightly diminished
upon the addition of ATP (Figure 4.9A, lanes 4-5). Interestingly, complex formation and
the binding of p23, FKBP52 and HOP to Hsp90 was slightly enhanced when the binding
solution was augmented with a 0.01% dose of non-ionic detergent (Figure 4.9A, lanes
3,6) [439]. This phenomenon was also represented in Native-PAGE experiments in
which the addition of non-ionic detergent appears to lead to a greater degree of Hsp902FKBP521-P232 and Hsp902-FKBP521-p232-HOP2 complex formation as indicated by the
relative disappearance of the independent p23 band (Figure 4.9B). This is likely
explained by the non-ionic detergent making the hydrophobic interaction between
Hsp90 and p23 more thermodynamically favorable.
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Figure 4.9 Co-immunoprecipitation and Native-PAGE experiments analyzing the relative
degrees Hsp902-FKBP521-p232 and Hsp902-FKBP521-p232-HOP2 complex formation in
the presence of varying buffering conditions. (A) Lanes 1-3 represent the relative
degree of Hsp902-FKBP521-p232 formation in the absence of ATP, in the presence of
ATP and with ATP plus 0.01% of a non-ionic detergent, respectively. Lanes 4-6 equate
to the same buffering conditions withheld in lanes 1-3 but with the additional
incorporation of HOP into the Hsp902-FKBP521-p232-HOP2 complex. The SDS-PAGE
image is surrounded by two additional lanes indicating the relative position of the Hsp90
antibody heavy (HC) and light (LC) chains (far left) as well as the anticipated distribution
of the target proteins (far right). (B) Native-PAGE results revealing a greater degree of
p23 incorporation into the respective Hsp902-FKBP521-p232 (Lanes 1-2) and Hsp902FKBP521-p232-HOP2 (Lanes 3-4) complexes in the presence of 0.01% non-ionic
detergent (Lanes 2 and 4).
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4.3.8 ANALYTICAL SIZE-EXCLUSION CHROMATOGRAPHY
In order to further illustrate the simultaneous binding of FKBP52 and HOP to
Hsp90, the Hsp902-FKBP521-p232-HOP2 complex was passed through a Superose6
size-exclusion column (Figure 4.10). Only a small fraction of Hsp902-FKBP521 -HOP2
complex was able to survive the relatively harsh separation process as a result of the
dynamic nature of its formation. p23 did not stay in complex with the other components
due to the fragility of the Hsp90-p23 interaction in the absence of ATP. This experiment
could not be executed in the presence of ATP without the negatively charged ATP
obstructing and finally occluding the sample flow through the chromatography column
due to ATP binding to the column matrix.

Figure 4.10 Analytical size-exclusion chromatography. (A) Size-exclusion
chromatogram highlighting the separation of the Hsp902-FKBP521-HOP2 complex (peak
1) from unbound constituents (peaks 2 and 3). (B) 10% SDS-PAGE results of the three
respective chromatographic peaks.
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4.3.9 STRUCTURAL ANALYSIS OF THE Hsp902-FKBP521-HOP2 COMPLEX
In order to visualize the simultaneous binding of FKBP52 and HOP to Hsp90, a
0.2mg/ml sample of the complex was negatively-stained with 2% methyl-amine
tungstate and examined by TEM (Figure 4.11). 6432 particles within 186 micrographs
were picked and sorted into 300 different class averages based on their shapes and
orientations within the respective micrographs. Iterative refinement of the data resulted
in a final set of class averages in which the individual classes were very heterogeneous
in shape and size indicating the existence of unbound substrates and various subassemblies. The best classes were selected based on their resemblance with the
previously solved X-ray structure of the Hsp902-p232 complex [399]. The selected
classes were appended into an initial model; however, refinement was discontinued due
to a lack of viable particles that ultimately resulted in a highly artifactual initial density
map.

Figure 4.11 Two-dimensional class-average images of Hsp902-FKBP521-HOP2 complex
particles observed at 80,000x. (top panel) Top/bottom views of the complex. (bottom
panel) Side views revealing noticeable densities that protrude from the body of the
Hsp90 scaffold. The crystal structure of the Hsp902-p232 complex (PDB 2CG9) was
adapted to highlight the orientation of Hsp90 (red and blue monomers) within the
respective class averages and theoretical binding locations of the FKBP52 and HOP
proteins (green).
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4.3.10 Hsp902-FKBP521-p232-HOP2 COMPLEX FORMATION
Dynamic Light Scattering was used to track the formation of the Hsp902FKBP521-p232-HOP2 complex as a function of the progressive increase in the
hydrodynamic diameter (d. nm) of the complex. Initially each of the substrate proteins
were measured separately to provide a baseline of their individual oligomeric states
(Figure 4.12A). p23 had the smallest hydrodynamic diameter reading of 7.5 nm while
FKBP52 and HOP revealed very similar measurements of 13.9 and 13.7 nm
respectively. Based on these results and the direct correlation between molecular
weight and the volume of spatial occupancy, p23 was found to be present in its
monomeric form while FKBP52 and HOP were found as dimers. The Hsp90 dimer was
subjected to DLS analysis resulting in a measured diameter of 17.6nm. DLS
measurements of Hsp90 were executed with and without ATP in an effort to capture
differences in the hydrodynamic diameter of the ‘closed’ and ‘open’ conformations.
However, the degree of variance between the two readings was too small to be
regarded as outside of the range of instrumental accuracy.
To investigate the progressive formation of the Hsp902-FKBP521-p232-HOP2
complex as a function of time, DLS measurements were taken over a 75 minute
incubation period in the presence of 5mM ATP, 20mM Na2MoO4 and 0.01% non-ionic
detergent. The shift from unoccupied Hsp90 through to the complete complex occurred
in the first 60 minutes with the hydrodynamic diameter increasing from 17.6 to 21.7 nm
(Figure 4.12B). More importantly this increase in diameter correlates with a large
volumetric increase as the hydrodynamic diameter and volume are exponentially related
(V=4/3 r3). Interestingly, the degree of complex formation was stabilized within the first
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60 minutes of the incubation. The hydrodynamic diameter of the complex did not
increase after 60 minutes.

Figure 4.12 Hsp902-FKBP521-p232-HOP2 complex formation revealed by DLS. (A)
Dynamic light scattering spectra of the p23 (blue), FKBP52 (red), HOP (green) and
Hsp90 (cyan) proteins illustrate diametric values that range between 7.6 and 17.6 nm as
depicted on a logarithmic x-axis. (B) The lateral shift in hydrodynamic diameter
(increase in size) of the Hsp902-FKBP521-p232-HOP2 complex (contrasting shades of
orange) over the course of a 75 minute incubation at 30°C. Each individual sub-panel
contains a bar graph representation of the DLS measurements outlined in the
respective colors. Error bars depict the standard deviation within a 95% confidence
interval.
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The formation of the Hsp902-FKBP521-p232-HOP2 complex was also followed in
a step-wise experiment revealing a gradual increase in the hydrodynamic diameter as
more constituent proteins were added to Hsp90 (Figure 4.13A). The addition of p23 to
Hsp90 in a 2:2 ratio resulted in a slight increase from 17.6 to 17.7 nm. This seemingly
insignificant increase is likely the result of the tight packing of the p23 molecules to the
amino-termini of the Hsp90 dimer as indicated by recent crystallographic data [399] and
as supported by the Co-IP results presented here. The incorporation of FKBP52 into the
Hsp902-p232 complex mixture resulted in an additional increase of 1.4 nm from 17.7 to
19.1 nm. More notable was the large increase in hydrodynamic diameter from the 19.1
nm Hsp902-FKBP521-p232 complex to the 21.7 nm Hsp902-FKBP521-p232-HOP2
complex (Figure 4.13A-right). The 2.6 nm increase in hydrodynamic diameter resulting
from the addition of HOP to the Hsp902-FKBP521-p232 complex indicated that HOP
most likely bound to Hsp90 as a dimer. Interestingly like HOP, FKBP52 also exists as a
dimer in solution but seemingly dissociates and binds to Hsp90 as a monomer whereas
HOP remains bound as a dimer. The degree of complex formation was also tracked as
a function of nucleotide availability revealing unchanged diameter readings even when
the sample was deprived of ATP (Figure 4.13B).
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Figure 4.13 Step-wise and nucleotide-based formation of the Hsp902-FKBP521-p232HOP2 complex analyzed by DLS (A) DLS captured the incremental rightward shift in
increasing hydrodynamic diameter as the individual components of the complex were
added to Hsp90 (cyan) in a step-wise fashion. p23 was first added to Hsp90 to yield the
Hsp902-p232 complex (blue). In subsequent steps, FKBP52 and Hop were added to
form the Hsp902-FKBP521-p232 (red) and Hsp902-FKBP521-p232-HOP2 (green)
complexes. (B) The shift in hydrodynamic diameter of the Hsp902-FKBP521-p232-HOP2
complex from the initial unbound Hsp90 (bright green) through to the complete complex
after 60 minutes in both the absence and presence of 5mM ATP, 20mM Na2MoO4 (red
and blue respectively). The results depicted in both sub-panels (A and B, left) are
graphed against a logarithmic x-axis. Additionally each individual sub-panel contains a
bar graph representation of the DLS measurements outlined in the respective colors.
Error bars depict the standard deviation within a 95% confidence interval.

102

4.3.11 STRUCTURAL ANALYSIS OF THE Hsp902-FKBP521-p232-HOP2 COMPLEX
In order to visualize the Hsp902-FKBP521-p232-HOP2 complex, a sample of the
complex was negatively-stained with 2% methyl-amine tungstate and examined by TEM
(Figure 4.14). At 100,000 x magnification the general shape of target particles within the
micrographs can be characterized as elliptical and very reminiscent of the Hsp902-p232
X-ray structure [399]. Some particles are oriented such that the separation in between
the two Hsp90 monomers is visible and heavily stained (Figure 4.14B). Other particles
are oriented such that a noticeable amount of bulging density is seen protruding from
one end of the Hsp90 dimer. One can postulate that these protrusions may be due to
the binding of the FKBP52 and/or HOP TPR domain-containing proteins.

Figure 4.14 TEM structural analysis of the Hsp902-FKBP521-p232-HOP2 complex. (A) A
negatively-stained TEM micrograph visualized at 100,000x magnification with isolated
particles boxed in red. (B) A close-up view of the individually boxed Hsp902-FKBP521p232-HOP2 particles. The individual particles on the right were normalized and
automatically contrasted in the BOXER program to highlight their general shape and to
outline their peripheral boundaries [148].

103

4.3.12 Hsp90 INTERACTIONS WITH THE CO-CHAPERONE SGTα
Co-immunoprecipitation experiments were used to analyze the competition
between SGTα and FKBP52 for the binding of Hsp90. Individual experiments were
performed in the presence of a monoclonal SGTα antibody in which the molar binding
ratio of FKBP52 was incrementally increased in separate experiments containing the
SGTα-baited Hsp902-SGTα1 complex (Figure 4.15). Initially a series of control
experiments were executed to show that FKBP52, Hsp90 and SGTα each showed no
binding affinity for a rabbit heavy chain antibody (IgG) and that only SGTα bound
specifically to the designated SGTα antibody. In the three proceeding experiments,
Hsp90 was added to the SGTα bait protein in a 2:1 molar ratio based on previous Ni2+affinity pull-down and yeast hybrid assay results [410,434] . In the final two of these
experiments FKBP52 was added to the Hsp90-bound SGTα bait protein in a 1:1 and 2:1
molar ratio respectively (Figure 4.15, lanes Hsp902-SGTα1 +FKBP521 and Hsp902SGTα1 +FKBP522). This resulted in the disappearance of the Hsp90 band (Figure
4.15B, lanes Hsp902-SGTα1 and Hsp902-SGTα1 +FKBP521) as the result of FKBP52
preferentially binding with Hsp90, hence relinquishing the ability of Hsp90 to bind with
the final SGTα-bound antibody/Protein A Sepharose bead pellets. These results indicate
that SGTα and FKBP52 do compete for the same binding site on Hsp90 and that the
binding affinity that Hsp90 has for FKBP52 is likely much greater than that for SGTα. It
is worth noting that the aforementioned competition for the binding site on Hsp90 could
not be characterized by regular SDS-PAGE (Figure 4.15A) but required the infinitesimal
sensitively of western blot analysis (Figure 4.15B) in order to be resolved. It is likely that

104

the weak affinity Hsp90 has for SGTα is due to the lack of important post-translational
modifications in the bacterially expressed SGTα substrate [440,441].

Figure 4.15 Co-immunoprecipitation experiments analyzing the competitive binding
between FKBP52 and SGTα for Hsp90. (A) Results resolved by 10% SDS-PAGE. (B)
Western blot analysis of the previous experiments using primary antibodies against
SGTα, FKBP52 and Hsp90.
The competitive action between SGTα and FKBP52 for the binding of Hsp90 was
further analyzed in a more direct fashion using Hsp90 as the bait protein in conjunction
with an Hsp90 antibody (Figure 4.16). Initial control experiments revealed the
exclusiveness of the Hsp90 antibody for specific binding with Hsp90 and not the SGTα
or FKBP52 proteins. Similar to previous experiments, SGTα was added to the Hsp90
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bait protein in a 1:2 molar ratio, with FKBP52 being added in variable molar quantities in
separate experiments (Figure 4.16, lanes Hsp902-SGTα1, Hsp902-SGTα1 +FKBP521
and Hsp902-SGTα1 +FKBP522). Interestingly the competitive binding for Hsp90 between
the two TPR domain-containing proteins could not be resolved by SDS-PAGE (Figure
4.16A) nor was it observed in BIO-RAD™ Experion experiments (Figure 4.16B) as
neither measure could detect the initial Hsp902-SGTα1 interaction. These results further
illustrate the extremely weak affinity Hsp90 has for the unmodified SGTα substrate.

Figure 4.16 The binding interactions between the Hsp90-bound antibody/Protein A
beads and the SGTα and FKBP52 proteins. (A) Co-immunoprecipitation results
resolved by 10% SDS-PAGE. (B) A computer-generated representation of automated
electrophoresis analysis performed on the respective Co-IP samples. The lower limit of
resolvability within the Experion package indicates that individual proteins can be
detected at concentrations at and above 2.5ng/µl.
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4.4

DISCUSSION
In previous studies the human Hsp90 has been found to exhibit selective

behavior for the binding of only one TPR domain-containing protein at a time
[377,435,436]. This behavior has also been observed for the yeast immunophilin and
HOP homologues cpr6 and Sti1 [49,419]. In the work presented here, a number of
biochemical and structural techniques were used to reveal the simultaneous binding of
two TPR proteins to the Hsp90 dimer. The binding of FKBP52 and HOP to Hsp90
appears to be extremely stable and can be facilitated under a number of environmental
conditions as indicated by co-IP, DLS, Native PAGE and electron microscopy
experiments. Yeast studies have postulated that the binding of the p23 homologue
Sba1 to Hsc82 is required prior to facilitating the binding of immunophilins [49,419].
However, the co-IP, Native PAGE, EM and analytical size-exclusion chromatography
results presented here indicate that the Hsp90-FKBP52 interaction occurs
independently of p23 and can occur readily in the absence of ATP. Apart from FKBP52,
HOP appears to interact with Hsp90 in a non-competitive fashion. Mutagenesis studies
indicate that the binding of HOP to Hsp90 is nucleotide-independent, however this
interaction can be weakened by the conformational changes induced by Hsp90’s
adaptation into the ATP-bound state [411]. The immunoprecipitation results presented
here support this notion to a limited extent; however, DLS results indicate that the
Hsp90-HOP interaction is also quite stable in the presence of 5mM ATP and 20mM
Na2MoO4. HOP also interacts with Hsp90 in the presence and absence of p23. These
results strikingly contradict previous findings that stipulate that the binding of p23
occludes or alters the stability of the binding site for HOP on Hsp90 [377].
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The stoichiometry and location of the interactions between FKBP52, HOP and
p23 with Hsp90 has previously been unclear and has lead to a number of ambiguities.
While all of the substrates maintain the ability to dimerize in solution, co-crystallization
experiments support the notion that FKBP52 binds to the -EEVD peptide located at the
far carboxy-terminus of each Hsp90 in a 1:2 molar ratio [422]. This hypothesis is further
supported the Native PAGE results presented here in which a 2:2 molar mixture of
FKBP52 to Hsp90 resulted in a large fraction of unbound immunophilin compared to
when the two entities were added in a 1:2 ratio. Much like FKBP52, HOP also has
binding affinity for the -EEVD motif [423] and can bind alternatively to the hydrophobic
middle-domain of Hsp90 [419,426,427]. The Hsp90-HOP interaction likely occurs in a
2:2 ratio as indicated by the work presented here and by other biochemical analyses
[49,411,442]. Based on class averages of the Hsp902-FKBP521-HOP2 complex, it
appears likely that FKBP52 binds with the middle domain of Hsp90 while the HOP dimer
interacts at the far carboxy-termini where the large spatial occupancy of the HOP dimer
can be accommodated (Figure 4.17). Additionally it appears that FKBP52 and SGTα
likely compete for the same site within the middle-domain of Hsp90 but due to the weak
affinity that Hsp90 has for SGTα, it remains unclear as to location where SGTα binds to
the Hsp90 dimer [410]. It is enticing to hypothesize over the Hsp90 binding positions of
the FKBP52 and HOP proteins based on the particles in the presented EM micrographs,
however further structural investigations are required to reveal the arrangement of these
intermolecular interactions.
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Figure 4.17 A theoretical model illustrating the simultaneous binding of HOP and
FKBP52 to Hsp90. The theoretical binding sites of HOP and FKBP52 onto the Hsp902p232 complex (blue/red and yellow, respectively) (PDB 2CG9) are outlined in green.
In a recent model of the chaperone-mediated regulatory cycle of the steroid
hormone receptor it has been postulated that there exists an intermediate assembly that
is comprised of client protein (receptor) bound to the Hsp90, Hsp70, Hsp40, HIP and
HOP proteins [443] (Figure 4.18A). Upon the binding of ATP to Hsp90, the Hsp70,
Hsp40, HIP and HOP proteins dissociate from Hsp90 and allow for the binding of
immunophilins like FKBP52 or cyclophilin 40, and the p23 co-chaperone. This Hsp902FKBP521-p232 assembly characterized a mature complex that is competent to facilitate
hormone binding [411,413]. While this model seems quite promising, the formation of
the Hsp902-FKBP521-p232-HOP2 complex revealed here indicates that the intermediary
role played by HOP is likely more substantial than previously described. HOP can
remain bound to Hsp90 in the presence of immunophilin and p23 and likely offers
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stabilizing effects that were previously offered to the client protein by the proteins of the
intermediate complex (Figure 4.18B). Once stabilized by Hsp90, HOP, FKBP52 and
p23, it seems likely that ATP hydrolysis within Hsp90 triggers the dissociation of ligandbound receptor for direct transport to the nucleus. However, it remains unclear as to
whether or not the ligand-bound steroid receptor travels alone to the nucleus or with the
accompaniment of Hsp90. Furthermore its remains to be seen whether an androgen
receptor/Hsp90 heterocomplex can permeate through the nuclear pores as has been
demonstrated in the mineralocorticoid receptor system [444].

Figure 4.18 General models of the chaperone-assisted regulatory cycle of steroid
hormone receptors. (A) A cartoon schematic diagram based on previous work
hypothetically outlining the proteins involved in early, intermediate and mature
complexes as the steroid hormone receptor is primed for binding with steroid hormone
(SH) and an interaction with the hormone response elements (HRE) of the nucleus
[411,412,413]. (B) Our newly proposed mechanism in which HOP offers stability to a
receptor-Hsp90-FKBP52-p23 heterocomplex in the absence of the Hsp40, Hsp70 and
HIP proteins. Colored proteins indicate those that were under investigation in this study.
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Despite the intrigue of the Hsp902-FKBP521-p232-HOP2 complex and its possible
involvement in the regulation of steroid hormone signal transduction, the importance of
its formation remains to be seen in the presence of purified hormone receptor.
Addressing this issue is a daunting task largely due to the difficulties associated with
producing functional amounts of stable client protein and the transient nature of the
receptor-chaperone binding interactions. It is likely that FKBP52 is present in the mature
receptor-chaperone complex as the FK-1 domain is believed to be largely responsible
for FKBP52-mediated potentiation of receptor efficiency by providing the binding surface
for the receptor [389,421,429]. However, whether p23 and/or HOP remain bound to
Hsp90 in the presence of the receptor remains unclear. Subsequent experiments using
a purified steroid receptor sample are required to shed light on this question in hopes of
further elucidating the roles p23, FKBP52 and HOP play in Hsp90-mediated steroid
hormone receptor regulation.
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